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ABSTRACT
The branched-chain amino acids leucine, isoleucine and valine

are transaminated to their respective a-keto acid analogues; a-ketoisocaproate (KIC) a-keto-p-methyIvalerate (KMV) and a-ketoiso-

valerate (KIV) in normal mammalian tissues.

Recently an interest

in the genetic anomaly "branched-chain ketoaciduria" or "maple
syrup urine disease", a metabolic disease involving the oxidative
decarboxylation of the three branched-chain CC-keto acids, has
stimulated efforts to characterize the nature of the enzymic
conversions leading from the a-keto acids to their acyl coenzyme A
products.

These studies have been extended toward a consideration

of the metabolic interrelationships among these a-keto acids (KIC,
KMV, KIV).

Furthermore, the effects of the branched-chain a-keto

acids upon the metabolism of pyruvate and of a-ketoglutarate have
been investigated.

In addition, there has been an attempt to

determine whether, in the normal and the abnormal (branched-chain
ketoaciduric) animal,

such interrelationships might constitute a

significant physiological regulatory mechanism.
a-Keto acid dehydrogenase activities were estimated by the
Ik
quantitative measurement of
keto acid substrates.

CO^ evolved from carboxyl-labeled a-

The a-keto acid dehydrogenase enzyme

activities were measured in several fractions of bovine liver
homogenates prepared by differential centrifugation techniques.

xii

Subcellular distribution studies established that the branched:hain a-keto acid dehydrogenase activities were localized principally
„n the mitochondri ., and more specifically on the outside of the
inner membrane of the mitochondria.

In addition to the particulate

activity, minor amounts of dehydrogenase activity with KMV and KIC
/ere noted in the "soluble" (not sedimented at 80,000 x £ for one
lour) fraction.
The particulate branched-chain a-keto acid dehydrogenase
activities were shown to depend upon added nicotinamide adenine
linucleotide (NAD+ ) and coenzyme A for maximal activity.

Also

jbserved were apparent requirements fox calcium, magnesium and
Inorganic phosphate.

These findings lend support to the assumption

:hat the branched-chain a-keto acids are catabolized by a mechanism
analogous to that known to exist for the well-characterized
ayruvate and a-ketoglutarate dehydrogenase complexes.
The apparent Michaelis constant for each of these keto acids
KIC, KMV, KIV, pyruvate, a-ketoglutarate) was determined.

In

general, the values for the branched-chain a-keto acids are of the
.
-h
>rder of 4 x 10
M, while those for pyruvate and a-ketoglutarate
-ij.
ire slightly lower, 0.8 x 10

M and 2 x 10

-I4.
M respectively.

The degree and type of influence exerted among the various a:eto acids was examined directly by following the enzymatic
.iberation of

lip
CO^ from carboxyl-labeled substrate in the presence

if an alternate unlabeled a-keto acid.

A mutually inhibitory

iattern among KIC, KIV and KMV was noted.

In addition, each of the

•ranched-chain keto acids exerted a marked inhibition of pyruvate
xiii

dehydrogenase and a-ketoglutarate dehydrogenase activities.
Inhibitions were of the competitive type in all instances except
for a-ketoglutarate dehydrogenase activity, where a "mixed" type
of inhibition was seen.

The apparent inhibitor constants were in

a range such that a significant mutual influence among the branchedchain a-keto acids could exist in vi ^o .

Also, the inhibitory

effects of KIC upon pyruvate dehydro '.anase could be considered to
be significant at normal cellular concentrations of these metabolite
The net effect of the inhibitory action of the branched-chain a-keto
acids on each other and upon pyruvate dehydrogenase in the normal
animal is likely a homestatic balance, which allows for catabolism
of excess branched-chain amino acids, while concurrently
influencing the flow of pyruvate to acetyl coenzyme A.
The abnormal situation, as obtained in branched-chain keto
aciduria, results in extremely elevated levels of all three branched
chain a-keto acids.

As these acids accumulate proximal to the

metabolic block at the level of oxidative decarboxylation,

they may

nearly completely restrict the activity of pyruvate dehydrogenase,
and exert substantial inhibitory effects at a-ketoglutarate
dehydrogenase.

These effects could severely limit the production

of energy via the Krebs tricarboxylic acid cycle.

In addition,

production of acyl coenzyme A intermediates necessary for fatty
acid synthesis would be affected.
Thus, as the result of a genetic.lesion, which is manifest in
the inability of the animal to catabolize the branched-chain a-keto
acids,

these intermediates accumulate, and in turn may exert a

deleterius influence upon cellular energy requirements, as well
as on production of essential metabolic intermediates.

These

effects in the abnormal situation could account for many of the
symptoms observed in branched-chain ketoaciduria.

xv

INTRODUCTION
The branched-chain amino acids leucine, isoleucine and valine,
which are synthesized in bacteria and plants, are essential nutrients
for animals.

Coon et al. (l) have studied the general pathways

for the degradation of these three amino acids in mammalian tissues,
and have found that the initial steps follow a similar pattern of
transamination to the respective a-keto acids (a-ketoisocaproate
(Kic)

1

, a-keto-p-methylvalerate (KMV), and a-ketoisovalerate (KIV),

followed by irreversible oxidative decarboxylation of these branchedchain a~keto acids to the corresponding acyl-CoA derivatives,
as noted in the following simplified reaction scheme:

1)

R-CH-COOH
i

—

--- ----- ------ R-C-COOH
H

HH2
2)

R-C-COOH
II

0
+

NAD'1' +

CoASH -v-- — > R-C-SCoA
^
II

0

C02

+

NADH

+

H+

°

The following abbreviations are used in this presentation:
KIC,
a-ketoisocaproate; KIV, a-ketoisovalerate; KMV, a-keto-p-methylvalerate: KB, a-ketobutyrate; KG, a-icetoglutarate; Pyr, pyruvate;
KV, a-ketovalerate; KC, a-ketocaproate; NAD+ , nicotinamide adenine
dinucleotide (oxidized form); NADH nicotinamide adenine dinucleo
tide (reduced form); CoASH, reduced coenzyme A; EDTA, ethylenediamine Lctm^ei-ic acid; NADP+ , nicotinamide adenine dinucleotide
phosphate; a-GP, DL-a-glycerophosphate; TPP, thiamine pyrophosphate;
FAD, flavin adenine dinucleotide, FMN, flavin mononucleotide; F^,
orthophosphate; g, gram; mg, milligram; £, gravity; ml, milliliter;
cm, centimeter; KA, absorbance change, nm, nanometers, M, molar;
rr.M, millimolar; min, minute; sec, second; l^COp, carbon-l^-labeled
carbon dioxide; cpm, counts per minute; kg, kilogram; nmole,
micromole; ug, microgram.
1

2

The further catabolism of the acyl-CoA compounds apparently
proceeds via a sequence of reactions similar to those of fatty acid
0-oxidation.

Sparse information is available on the enzymes which

are involved in these catabolic pathways.

However, from the studies

of Bloch (2) and Coon (3) it is evident that certain of the later
reactions in the pathways of branched-chain amino acid degradation
differ considerably from the accepted 0-oxidation scheme.

With

respect to end-products formed from the catabolic processes involved,
it is generally understood that leucine is ketogenic, valine is
glycogenic and isoleucine is either ketogenic or weakly glycogenic
under varying conditions (I+-7 ) .

It has been postulated that the

overall oxidative decarboxylation of KIC, KMV, and KIV proceeds
by a metabolic conversion analogous to that proposed for pyruvate
and a-ketoglutarate.

Gunsalus (8) and Reed (9 ) have presented the

following mechanistic scheme to account for the reaction sequence
of the oxidation of pyruvate and a-ketoglutarate by their
respective enzyme complexes;

3)

.x
4)
7

0
II
R-C-COO
OH
1
R-C-TPP-enz

+

a

TPP-enz

+

OH
l
---------- ■> R-C-TPP-enz

a

S--- <

lip-enz,
b

O

... -....

a

>

S --- '
0
II
R-C-S-

lip-enz
+

HS'

TPP-enz

a

+

C0„
^

3

o

lip-enz

~5

5)

+
II
R-C-SCoA

n
R-C-S

HS-CoA
^lip-enzb

+

HSHS

HS
lip-enz

6)

HS

+

3

FAD-enz

HS
lip-enz.

:5
7)

FADH -enz
2
c

+

0
II
R-C-COO

Sum:

In this scheme enz

+ FADH -enz
2
c

NAD

FAD-enz

+

c

NADH

H

+
+

CoASH

+

NAD

0
II
R-C-SCoA

+

CO

a,b,c,

+

NADH

+

+
H

represent the respective decarboxylase,

acyl transferase and lipoyl dehydrogenase components of the
complex, lip indicates the carboxyl terminus of lipoic acid,
TPP represents the prosthetic group thiamine pyrophosphate, and
the various carbon skeletons of the keto acids are designated by
R, where R may be as follows:
CH_

CH,
CH-

ch3

\
/

CH,

\

CH-

/
c 2H5

, or
CH

CH-CH2"

FAD and FADH^ represent the oxidized and reduced forms of flavin
adenine dinucleotide respectively.

1+

Recently the obligatory participation of CoA and NAD+ has been
observed in the enzymic oxidative decarboxylation of KMV, KIC and
KIV by extracts of Bacillus subtilus (10) and rat liver (11).
Evidence for the active participation of the other presumptive
cofactors is largely indirect.

Lipoic acid was determined to be

essential for the oxidative decarboxylation of KMV and KIV in
Streptococcus faecalis cells harvested from a lipoic acid deficient
medium (12), and added thiamine pyrophosphate resulted in slightly
increased KMV dehydrogenase activity in B, subtilus extracts (10).
Direct evidence for the function of lipoic acid and thiamine
pyrophosphate as prosthetic groups of the branched-chain cn-keto
acid dehydrogenase systems of mammalian tissues has not been
available.
Liver and kidney possess the highest branched-chain a-keto
acid dehydrogenase activity in the rat (11); low levels were
observed in heart and brain tissue, and no oxidative decarboxylation
of these compounds was obtained from preparations of skeletal
muscle.

A general survey of branched-chain keto acid oxidative

decarboxylase capacity of several mammalian species (13) indicated
that bovine liver homogenates catalyzed the oxidation of KIC at a
substantial rate, with a specific activity higher than that of most
other tissues studied.
Several aminotransferases which will accept branched-chain
amino acids as a substrate have been reported.

Such an instance

occurs in Escherichia coli, where one valine-specific and two
leucine-accepting transaminase enzymes are indicated (l^).

Taylor

5

and Jenkins (15 ) have isolated an aminotransferase from pig heart
cytosol which accepts leucine, isoleucine, valine or glutamic acid
as the amino group donor, and the related a-keto acids, a-ketoisocaproic acid, a-keto-(3-methylvaleric acid, a-ketoisovaleric acid
and a-ketoglutaric acid as the amino group acceptor.

Availability

of amino group acceptor appears to be a possible rate-limiting
step for the oxidative of L-valine (l6).

These transaminases are

generally located in the non-particulate fraction in mammalian
cells (11).
Branched-chain ketoaciduria (BCKA), also known as "Maple
Syrup Urine Disease" (MSUD) because of the characteristic odor of
the urine and bodily secretions, is a metabolic error of genetic
origin which involves the degradation of the amino acids leucine,
isoleucine and valine.

Menkes (17 ) first described this disease

in a family in which four infants died within several weeks of
birth.

Characteristic symptoms observed were vomiting, muscular

hypertonicity, and a penetrating "maple syrup" odor to the urine.
A subsequent report by Dane is (18) involved a similar event in
which the infant died at 20 months of

ge possessing the symptoms

of maple syrup odor, brain damage and generalized lethr.rgy.
Analysis of plasma and urine revealed abnormally high concentrations
of the branched-chain amino acids and their a-keto acid analogues.
Numerous instances of the disease have since been reported (19 ).
Snyderman (19) and Westall (20) have successfully treated
branched-chain ketoaciduric patients with dietary therapy, the mode
of which consists of reduced and carefully balanced consumption of

-V;
'Si: :

if ■
w.

6

branched-chain amino acids.

This therapy is most likely to succeed

in preventing the alterations of neurophysiology, and other
characteristic symptoms, if begun in the first week of life.

It

thus appears that the neonatal brain is particularly sensitive to
high levels of branched-chain amino or a-keto acids.
Dancis (18,21,22,23*24) has proposed that the metabolic lesion
effecting a block in the catabolism of the branched-chain amino
acids and responsible for the genetic anomaly BCKA is a lack of,
or a malfunction of, the enzyme or enzymes responsible for the
catalysis of the oxidative decarboxylation of the branched**chain
a-keto acids KIC, KMV, and KIV (refer toequation 2 above).

Normal

function of the transaminase enzymes has been observed in tissues
of these individuals (25)«
In an attempt to clarify further the nature of the impairment
in branched-chain amino acid metabolism in BCKA, a general aim
of several investigations (22,26,27) has been to determine whether
three specific dehydrogenase enzyme complexes are responsible for
the oxidation of KIC, KMV and KIV, or whether a single less
specific enzyme complex may catalyze the catabolism of all three
keto acids.

This question is of general interest, since the answer

could provide significant information concerning the regulation of
these metabolic pathways, and give pertinent insight bearing on
the comprehension of the associated genetically determined metabolic
disease.

Current information would indicate that one of four major

possible occurrences could account for the observed branched-chain
amino acid and keto acids at elevated levels as noted in the

7

diseased (BCKA) patient.
A.

All of the branched-chain a-keto acids are oxidized
by one enzyme, which is genetically altered (22).

B.

Each branched-chain a-keto acid is catabolized by a
separate dehydrogenase

C.

of which all are malfunctioning (26).

Each branched-chain a-keto acid is acted upon by a
separate enzyme, only one of which is genetically altered.
The resulting accumulation of intermediates acts to
hamper the activity of the other two enzymes.

D.

Two of the a-keto acids (KMV and KIC) may be catabolized
by one enzyme, the activity of which may be affected by a
genetic lesion, with a resulting increase in the
concentrations of KMV and KIC in the cell acting to
inhibit the metabolism of the third branched-chain aketo acid, KIV (27).

Moms

(28,29) and Dane is (23) have observed a variant form

of BCKA which is not necessarily fatal and does not appear to result
in significant mental retardation.

They suggest that these

individuals may possess a partial enzymic defect, since the
peripheral leukocytes exhibited some decarboxylative activity with
the branched-chain a-keto acids, as compared to the complete absence
of branched-chain a-keto acid oxidative capacity in leukocytes
obtained from patients with the classic branched-chain ketoaciduria.
These investigators speculate that an entire spectrum of branchedchain a-keto acid dehydrogenase activities may be present in the
general population; ranging from absence of the decarboxylase

8

activity in the classic BCKA individual to the full enzyme
complement in normal tissues.

Harris (30) has

presented

significant data with respect to a similar occurrence among certain
other enzymes in the red blood cell.
Since the discovery of branched-chain ketoaciduria in humans,
a number of investigators have proposed possible modes of action
whereby the elevated levels of the branched-chain amino and keto
acids may produce the observed physiological and neurological
symptoms.

Observations on patients undergoing dietary treatment

have demonstrated that the acute symptoms (ataxia, convulsions)
appear to be more closely related to elevated levels of leucine
than of isoleucine or valine (31 ,32).
Tanaka, e_t a_l. (33) have recently obtained evidence for a
new disorder of leucine metabolism, isovaleric acidemia, in which
there is a defect in the further catabolism of isovaleryl-CoA,
the oxidative product of KIC degradation.

This metabolic error

results in the accumulation of isovaleric acid, formed by
deacylation of isovaleryl-CoA, in plasma and urine.

Symptoms of

the disease, in addition to the elevated plasma levels of iso
valeric acid, included ata.via and loss of muscle coordination.
No increase in the serum concentrations of the branched-chain amino
acids or a-keto acids was noted.

The fact that leucine and KIC

were not significantly increased in the plasma of the patients would
probably be explained by the apparent irreversibility of KIC
oxidative decarboxylation.
Autopsy examinations of several diseased BCKA patients have
been described (16 ,3^+) in which similarities were observed with

9

respect to a striking deficiency of myelination in certain primitive
areas of the brain, and a spongy character to the white matter.
The absence of degradation products of myelin suggested that the
lack of myelination resulted from an interruption of the synthesis
normally occurring after birth.

Silberman, et al. (3^+) have

suggested that increased keto acid concentrations in the developing
brain may decrease the synthesis of cerebronic acids, considerable
amounts of which are necessary components of myelin.

However,

there is no suggestion that these findings are a direct and
quantitative effect of the elevated leucine, isoleucine, valine or
their corresponding keto acids.

Howell (35) found that KIC and KIV

were able to inhibit oxygen consumption by brain slices, and
postulated that this phenomenon could account for the impaired
function of this tissue in BCKA.

The findings of Tashian (36)

lend support to these data.
There has been considerable discussion regarding a possible
site of inhibition by the abnormal accumulation of metabolites
proximal to the metabolic block.

Among these reports are the

observations that various levels of branched-chain a-keto acids
tend to inhibit the activity of glutamic acid decarboxylase in
brain and liver of the rat (35 >36,37).» as weH

as more recent

indications that this enzyme is not significantly affected by KIC
concentrations below 1.0 mM.

Decarboxylation of glutamic acid

produces gamma-aminobutyric acid (GABA) which may participate
in the process of transmission by inhibitory neurons (36).
Another possible mechanism of toxicity of the branched-chain
amino and keto acids is inhibition by these compounds at the'level
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of pyruvate dehydrogenase in the glycolytic pathway, or at aketoglutarate dehydrogenase of the tricarboxylic acid cycle.
Recently Kanzaki (38) has found that the activity of a-ketoglutarate
dehydrogenase purified from pig heart muscle is inhibited by KIC,
KMV and KIV.

Pyruvate dehydrogenase isolated from the same tissue

source was inhibited by KMV and KIV; however the effects of KIC as
an inhibitor of the purified pyruvate dehydrogenase complex were not
discussed.

Other investigators (37) have studied the inhibition of

pyruvate dehydrogenase by the branched-chain a-keto acids from a
semi-quantitative viewpoint, and have reported varying degrees of
inhibition by KIC in rat brain and liver homogenates (13*37) anc^
in rat liver slice preparations (39)•
These preliminary observations indicate a necessity for further
investigation into the mode and the extent of the effects of
branched-chain a-keto acids, at the concentrations obtained during
normal metabolism and in manifestations of BCKA, upon these two
very important segments of intermediary metabolism.

Since the

glycolytic pathway and the tricarboxylic acid cycle are considered
to be of fundamental importance to the provision of energy
equivalents in the form of the reduced nucleotide coenzymes, a
disruption of function at either site could conceivably be of
serious consequence to the cell in terms of general oxidation
state and in production of energy necessary for anabolic processes.
Decreased pyruvate dehydrogenase activity would also result in
lowered production of acetyl-coenzyme A for the tricarboxylic
acid cycle and for fatty acid and steroid synthesis.
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Leucine and alloisoleucine have been observed to inhibit
gluconeogenesis slightly in concentrations in 1.0 mM (1+0,1+1).
Instances of hypoglycemia induced by high levels of leucine have
also been reported (1+2).
From the viewpoint of regulatory interrelationships among
the keto acids the metabolism of branched-chain amino and keto
acids in normal tissue has received less attention than has the
pathology of the diseased tissues of the individual with B C K A .
An apparent antagonism among the branched-chain amino acids
has been noted by Harper et al. (1+3) and by Snyderman (32).

This

antagonism is expressed as an imbalance in the ratios of plasma
leucine, isoleucine and valine, resulting in decreased rates of
growth in rats.

Wohlheuter and Harper (11) have reported an

increased rate of branched-chain a-keto acid dehydrogenase activity
in rats fed a 30 per cent casein diet, or a diet containing nine
per cent casein plus additional amino acids.

Tito general types of

increased activity were noted, one of which could be blocked by
cycloheximide.

A diurnal variation in branched-chain a-keto acid

dehydrogenase activity was also noted.
The above phenomena suggest that there may be mutual metabolic
interrelationships among branched-chain amino acid a-keto acids
which are not obvious merely from a consideration of the individual
degradative pathways.
STATEMENT ur rkOBLEM

The aim of the present investigation is to characterize the
utilization of and the i_n vitro metabolic interrelationships among

..’ ^
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the branched-chain a-keto acids in preparations of bovine liver
tissue; and secondly, to ascertain whether the influences of
branched-chain a-keto acids upon the metabolism of pyruvate and aketoglutarate could constitute a significant physiological
regulatory phenomenon.

Among the specific aspects of the above

primary objectives considered in this study are the elucidation
of the apparent location of the branched-chain a-keto acid
dehydrogenase activities in the bovine liver cell and an investigation
of the apparent requirements for coenzymes.

Data pertaining to

the determination of the number of enzymes responsible for the
catalysis of the oxidative decarboxylation of a-ketoisocaproate,
a-keto-p-methylvalerate, a-ketoisovalerate, a-ketoglutarate and
pyruvate are presented.

An attempt has been made to determine and

to describe the relative extent and the apparent mode of inhibitory
interactions among these metabolites.
The results of these investigations are discussed in relation
to the cellular levels reported for these a-keto acids in normal
tissues and with respect to the observed elevation of KIC, KMV
and KIV in the pathological conditions associated with branchedchain ketoaciduria (BCKA).

METHODOLOGY
Reagents and Materials

The chemicals used in these studies were obtained from the
following sources:

f3-nicotinamide adenine dinucleotide (NAD+ ) ;

trilithium coenzyme A; sodium salts of a-ketoisocaproate, aketoisovalerate, cn-keto-p-methylvalerate, a-ketobutyrate, aketoglutarate, a~ketovalerate, a-ketocaproate, pyruvate,

succinate,

malate, pyruvate and D,L-a-glycerophosphate; L-amino acid oxidase;
D-amino acid oxidase; Dowex 50-W (200-i+00 mesh) ion exchange resin;
Sephadex G-25 gel beads; triethanolamine-hydrochloride; antimycin A;
oiigomycin; protamine sulfate; L-cysteine;

nicotinamide adenine

dinucleotide phosphate (NADP+ ) ; para-chloromercurisulfonate; bovine
serum albumin; D,L-a-lipoic acid, thiamine pyrophosphate;

flavin

adenine dinucleotide (FAD); flavin nonucleotide (FMN); catalase;
/
\
ll+
digitonin; (Sigma Chemical Co., St. Louis, Missouri); L-leucine-1- C,
lij.

DL-valine-1-

1^.

C, sodium pyruvate-1-

lip

C, sodium a-ketoglutarate-1-

C,

(New England Nuclear, Boston, Massachusetts) ; L-isoleucine-U-^C
(Cal-Atomic Division, Calbiochem Co., Los Angeles, California);
l,4-bis-2-(5“phenyloxazolyl)-benzene (POPOP), 2,5 diphenyloxazole
(PPO), hydroxide of hyamine 10-X, low potassium glass scintillation
vials (Packard Instrument Co., Downers Grove, Illinois); 2,k
dinitrophenylhydrazine, ethylene diamine tetraacetate (disodium
salt), hexyl alcohol (Eastman Organic, Rochester, New York); 2,6
dichlorobenzone indophenol, urea, sodium arsenite, potassium
13
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ferricyanide, Folin-Ciocalteau phenol reagent, monobasic sodium
phosphate, dibasic sodium phosphate, monobasic potassium phosphate,
dibasic potassium phosphate, calcium chloride, sodium carbonate,
magnesium chloride and other analytical reagent grade chemicals
(Baker Chemical Co., Chicago, Illinois); mannitol, ammonium
acetate, acetone, charcoal (Mallinkrodt Chemical Works, St. Louis,
Missouri); toluene, sucrose (Fisher Scientific Co., Chicago,
Illinois); Triton X-IOO (Ruhm and Haas, Philadelphia, Pennsylvania);
iso-amyl alcohol (Matheson, Coleman and Bell, Norwood, Ohio);
adenosine triphosphate (P-L Biochemicals, Milwaukee, Wisconsin);
EDTA-recrystallized ammonium sulfate (Mann Research Biochemicals,
New York, New York); Blue Dextran 2000 (Pharmacia, Uppsala, Sweden);
Bio-Gel P-2 (BioRad, Richmond, California).

All other chemicals

were of analytical reagent grade.
a-Ketoisocaproate-l-^\: (sodium salt), a-ketoisovalerate-1-^C
(sodium salt) and a-keto-f3~methylvalerate (sodium salt) were
synthesized from the appropriate labeled amino acids prior to use
as described below.

All water used in these studies was distilled

and deionized (Corning 3508A double bed resin).

Detailed methods

for preparation of solutions of reagents are shown in Appendix I.
Preparation of

1^
C-labeled u-Keto Acids

Carbon-l4-carboxyl-labeled a-keto acids were prepared with
modifications of the method of Meister (44).

L-amino acids are

oxidized to the corresponding a-keto acids by L-amino acid oxidase
in the presence of catalase.

After removal of protein the a-keto

acids can be purified by ion exchange chromatography and isolated
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as the crystalline sodium salt.
Snake venom L-amino acid oxidase (300 mg) dissolved in 20 ml
of water is dialyzed against running water at 5°C for 12~2b hours.
Crystalline bovine liver catalase is also dialyzed against
running water at 5°C for 12 hours to remove preservative.
Two grams of the L-amino acid are suspended in 50 ml of water,
to which is also added 50-100 microcuries of

14
C-labeled amino

acid, catalase (100 units) and the L-amino acid oxidase.

The

solution is adjusted to pH J.2 with 0.5 N NaOH and the volume
brought to 100 ml with distilled water.

One ml of hexyl alcohol

's added to prevent foaming, and oxygen gas is bubbled continuously
through the mixture.

The reaction is allowed to continue at 37°0

for S~2k hours, or until keto acid analyses (spectrophotometnc
measurement of dinitrophenylhydrazone derivatives) indicate no
further increase in a-keto acid formation.

The pH of the solution

is adjusted to pH "J.2 with 0.5 N NaOH as needed.
The a-keto acid is separated from protein by gel filtration
of the reaction mixture on a Sephadex G-25 column (3 cm x ^5 cm)
at a flow rate of 1.0 ml per minute.

Collected fractions were

analyzed for radioactivity by liquid scintillation spectrometry
and for protein by spectrophotometric determination of relative
absorbance at 260 and 280 nm in a Beckman Model DU-2 multiple
sample spectrophotometer.
radioactivity was obtained.

Complete separation of protein from
Highest activity fractions (90-95

per cent of total radioactivity) were combined and evaporated in
a reduced pressure distillation apparatus at 26 mm pressure and

16
35°C.

The concentrated solution thus obtained was passed through a

Dowex 50-W cation exchange resin (H+ form), and the a-keto acid
eluted with water at a flow rate of 0.5 til per minute.

All

fractions were analyzed for amino acid with ninhydrin reagent
and for radioactive label by liquid scintillation spectrometry.
Fractions containing 90-100 per cent of remaining radioactivity and
no amino acid contaminant were combined, adjusted to pH 4.5 with
5 N NaOH, and evaporated to a volume of less than 10 ml under
reduced pressure.
Fifty to sixty volumes of ice-cold acetone were added slowly
and the sodium salt of the cc-keto acid allowed to crystallize at
0°C.

The crystals were filtered over reduced pressure,

recrystallized from concentrated aqueous solution by addition of
ice-cold acetone, filtered and washed with acetone followed by dry
diethyl ether on the filter.

The crystalline sodium salt of the

a-keto acid was then dried in a vacuum dessicator over sodium
sulfate.

Radiochemical purity of the compounds was ascertained by

chromatographic (4-5) and spectrophotometric (45) determination,
using the 2,4-dinitrophenyi hydrazone derivatives (45)*

2,4-

Dinitrophenyl hydrazine (0.1$ solution in 2N hydrochloric acid)
was mixed in a slight volume excess with a sample of an aqueous
solution of the a-keto acid to be analyzed.

The crystals of the

2,4-dinitrophenyl hydrazone derivative were allowed to form in
the dark.

These crystals were recrystallized from hot water,

dissolved in ethanol (95%) and chromatogrammed on thin-layer silica
gel plates.

The

values were determined after development of the
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plates, and compared to

values for the known a-keto acid

derivatives.
The chromatogram spots were eluted into 0.5 N NaOH and spectra
recorded from 700 nm to 350 nm on a Cary Model 15 recording spectro
photometer.

These spectra were then compared with those of pure a-

keto acid 2,4-dinitrophenylhydrazone derivatives.
Enzyme Assay Methods
A.

a-Keto acid dehydrogenase activities were estimated using

modifications of the methods utilized by Wohlheuter and Harper (11)
and by Snyder (46), in which the amount of labeled carbon dioxide
evolved from carboxyl-labeled a-keto acids is measured after
incubation with various tissue preparations.

The final reaction

volume of 1.0 ml usually contained the following constituents,
in micromoles:

f3-NAD+ , 1.0; Li^ CoA, 0.6; potassium phosphate

buffer, pH 7.2, 33; manniu.l, 150; Ca C ^ , 1.0; MgCl^, 1.0;
Na^CO^j 1.0; appropriate amounts of a-keto acid-1enzyme (2~3 mg protein), and water to 1.0 ml.

14
C substrate,

The reactions were

generally initiated by addition of enzyme by pipette.

Flasks were

capped immediately and swirled gently to facilitate mixing.
Warburg flasks, or small Erlenmeyer flasks with a center
well, served as reaction vessels (Figure l).

A small test tube

(10 mm x 20 mm) containing 0.5 ml of hydroxide of Hyamine 10X
was placed on the center well and the flask was tightly capped
v/ith a rubber serum cap.

The reactions were allowed to proceed

for 20 minutes, or other specified time interval, at 30°C in a
shaking water bath, after which time 0,2 ml of 2.0 N sulfuric acid
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Fig. 1. - Diagram of Incubation Flask used for

Assay

Incubation

flask

rubber cap
C 0 2 "trapping vial"

'!'vif-i'

f M

20
was added to the reaction mixture by syringe through the rubber cap.
The acid stopped the enrymic reaction and released the dissolved
lii

CO^ from solution.

Distillation of

14

CO^ into the Hyamine was

allowed to continue, with shaking, for one additional hour, at
which time the tube and its contents was transferred to a
scintillation vial containing 10 ml of a scintillation fluid /O.U °]o
2,5"diphenyloxazole, 0.01 %, 1,if bis-2-('5-phenyloxazolyl)-benzene,
in toluene, w/v/, and counted three times for 10 minutes in a
Packard Tri-Carb liquid scintillation spectrometer (Automatic
Model 500-E).

The following settings were employed:

100 per cent gain.
minute (cpm).

9^-0 volts,

The average background was 30 counts per

Samples were run in duplicate or in triplicate.

Blank values were determined by carrying boiled enzyme preparations
through an identical procedure.

Blank values of 10 to 30 cPm above

background were consistently observed for any one a-keto acid
14
preparation, possibly resulting from traces of

CC^ in the a-keto

solutions and a slow non-enzymatic decarboxylation.
assays measured in the range of 500 to 1500 cpm.

Typical

The amount of CO^

produced was calculated from the specific activity of the carboxyl
labeled 1-^C-substrate.

Results are expressed in units, defined

as nanomoles of CO^ per minute; specific enzyme activity is
expressed as units per mg of protein.
A modification of the above procedure, utilizing ferricyanide
as an artificial electron acceptor, was also investigated and found
to be a less sensitive measure of a-keto acid oxidation.
comparison of the two methods is shown in Figure 2.

A
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Fig, 2. —

Comparison of NAD+ and ferricyanide as electron

acceptors for the

The amount of

li|
COg assay of a-keto acid dehydrogenases

14
14
CO^ evolved from a-ketoisocaproate-l- C in the presence

of a washed preparation of bovine liver mitochondria during a 20 min
incubation period at 30° C was measured with either NAD+ or ferricyanide
as the electron acceptor for the oxidation reaction.

Each reaction

mixture contained, in a final volume of 1,0 ml, the following (in pmoles)
mannitol, 150; potassium phosphate buffer, pH 7*2, 335 MgC 1^, 1.0;
CaC1? , 1.0; Na^CO^j 1.0; NAD+ , 1.0, and Li^CoA, 0.6; or K^Fe(CN)g ,

0.05;

l-^C-KIC, 2.0 (3700 cpm per pinole); and the indicated quantities of
enzyme solution as shown on the figure.
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B.

a-Ketoglutarate dehydrogenase purified from pig heart

muscle was assayed by the modification of the method of Searles and
Sanadi (1+7), in which the formation of NADH with time was measured
at 31+0 run on the Cary 15 or the Beckman Model DK-2 dual beam recording
sp ectro p h oto m eter.

3
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intermediate (8).

Gubler (48) has described a continuous assay

which involves following the reduction of ferricyanide (Fe(CN)g

)

with time at 420 nm as a measure of the decarboxylation of a-keto
acids by suspensions of mitochondria.

A typical reaction, mixture

contained the following components in pmoles, in a calibrated
mixing tube:

potassium phosphate buffer, pH 7*2, 150; ATP, 6.0;

EDTA, 7.0; MgSO^, 20; TPP, 0.5; K^Fe(CN)^, 3.34; a suitable amount
of enzyme preparation, and 0.25 M sucrose to a final volume of

6.8 ml.

These constituents were mixed by inversion and divided

equally between two 1-cm matched cuvettes.

The Cary Model 15

recording spectrophotometer was balanced to zero with the cuvettes
in position, at which time the substrate in a volume of 0 .1 ml was
added to the reference cell, mixed rapidly by inversion, and the
recording begun immediately.

Emaxlt20 of 1>05 x 10

assumed (13 ) for FefcN)^

3

-1
M

-1
cm

iS

\ The slope of the line traced

100 second time interval is assumed to correspond to iimoles of
a-keto acid oxidized in one minute.
D.

Succinate dehydrogenase was measured according to the

method of Bonner (49) by following ferricyanide reduction at 412 nm
in a Cary Model 15 dual beam recording spectrophotometer.
E.

Glycerol-l-phosphate dehydrogenase activity of washed

preparations of liver mitochondria was determined by the method
of Klingenberg (50), in which reduction of ferricyanide at 412 nm
is followed on a Cary Model 15 recording spectrophotometer.
F.

Glucose-6 -phosphate phosphohydrolase activities were

determined by the revised method of Nordlie and Arion (51)•
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Klingenberg (50) has shown, that ferricyanide does not penetrate the
intact inner membrane.
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substrates, and antimycin A as indicated in the appropriate legends.
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C i-K e to A c i d

P e rm e a tio n

in M ito c h o n d ria

T h e general impermeability of the inner membrane of

mitochondria toward various anions such as the branched-chain Gketo acids was estimated indirectly by following the rate of change
in optical density at 515 nm of a mitochondrial suspension in the
presence of high concentrations of the keto acid and of a cation
which readily equilibrates across the membrane (53)-

Such a

permeable cation with an anion which is also permeable would result
in rapid influx of water with the concomitant increase in
mitochondrial volume (swelling).
I n the typical swelling experiments the reactions were conducted

in matched 1-cm cuvettes.

The suspension of mitochondria was diluted

with 0.3 M mannitol so that 0.1 ml of the suspension contained
approximately 0.5 mg of protein.

This amount of mitochondria in

a total volume of 1,5 ml gave an optical density near 0.6 at 515 ran
on a Cary Model 15 recording spectrophotometer, which was balanced
to zero prior to addition of mitochondria.

One-tenth ml of the

suspension of mitochondria was added to the reaction cuvette and
mixed rapidly.

The optical density change with time was fol owed

until swelling had occurred and the optical density had leveled
off, or for a convenient time intervals.

This spectrophotometric

determination of swelling gives qualitatively reliable measurements
of mitochondrial volume changes (5^).
Enzym e P r e p a r a t i o n s

Bovine liver mitochondria were prepared by a modification of
the procedures utilized by Lusty and Singer (55)•

Fresh bovine

27

liver was obtained from the slaughter house, 10 to 15 gm of tissue
were placed in a pre-weighed beaker containing a solution of 0,3 M
mannitol, which was 10
surgical scissors.

-1+

M with respect to EDTA, and minced with a

The tissue was transported to the laboratory-

in this container, weighed and homogenized with approximately 10
-k
volumes of 0.3 M mannitol - 10
glass homogenizer.

M EDTA in a Potter-Elvehjem

The crude homogenate thus obtained was then

centrifuged at 600 x £ for 10 minutes to remove cell debris and
nuclei.

The supernatant fraction was decanted and saved.

The

nuclear fraction (nuclei and cell debris) was resuspended in about
30 ml of 0.3 M mannitol - 10 ^ M EDTA and recentrifuged at 600 x £
for 10 minutes.

The combined supernatant fractions were centrifuged

at 9,600 x £ for 10 minutes.

The mitochondrial pellet was

resuspended in 0.3 M mannitol - 10
9,600 x £ for 10 minutes.

-k

M EDTA and centrifuged at

The resulting pellet was gently
—k

suspended in 0.3 M mannitol - 10
ml per gram wet liver tissue.

M EDTA to a final volume of 1,0

The protein concentration of this

washed preparation of mitochondria varied from 23 to 28 mg per
milliliter.
Further differential centrifugation procedures were utilized
to obtain microsomal and soluble fractions.

The supernatant

fraction of the first 9,600 x £ spin was centrifuged at 80,000 x £
for one hour in a Beckman Spinco Model L preparative ultra
centrifuge (number 30 head).

The precipitate of this spin was

termed the "microsomal fraction", and the supernatant fluid was
denoted as the soluble or "supernatant" fraction.
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Rat liver mitochondria preparations were obtained by techniques
slightly modified from those utilized by Schneider (56).

All rat

liver mitochondria were obtained from male Sprague-Dawley rats

(200 to 300 gm); the liver was removed immediately after
decapitation and bleeding of the rat, blotted, placed in a preweighed
beaker containing ice-cold 0.25 M sucrose and weighed.

The liver

was then finely minced with a stainless steel scissors in
preparation for homogenization.

The liver was homogenized in a

Potter-Elvehjem glass vessel with a Teflon pestle.

The ten tc

fifteen grams of liver were homogenized in three equivalent portions
of twenty-five to thirty ml of cold 0.25 M sucrose.

The vessel and

pestle were then rinsed in approximately ten ml of 0.25 M sucrose
which was added to the homogenate to give a total volume of eighty
to one hundred ml.

The homogenate was centrifuged at 600 x

for ten minutes in an International Model B-20 refrigerated
centrifuge with the number 87O head, to remove blood cells, cell
nuclei and other cell debris.
and saved.

The supernatant solution was decanted

The "nuclear" residue was washed and homogenized with

twenty ml of 0.25 M sucrose, centrifuged at 600 x
and the supernatant decanted and saved.
fractions were centrifuged at 8,500 x

for 10 minutes,

The combined supernatant
for 10 minutes.

The

supernatant fraction which contained the microsomes was decanted
carefully and discarded.

The mitochondrial pellet was rehomogenized

in thirty ml of cold 0.25 M sucrose and centrifuged at 8,500 x g
for 10 minutes.

The final pellet was suspended in 0.25 M sucrose

to a volume equal to 1.0 ml per gram wet liver tissue.

The protein
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concentration of this washed preparation of mitochondria varied
from 25 to 30 mg per ml.
S o lu b iliz a tio n

by D i g i t o n i n

of

O u ter

M em brane o f M i t o c h o n d r i a

Treatment of isolated mitochondria with 1 per cent digitonin
(w/v) solution has been shown to remove outer membrane and intramembranal proteins from the inner membrane-matrix complex (57)•
An aliquot of a suspension of mitochondria containing 100 to
160 mg of protein per ml is cooled in an ice bath.

Cold 2 per

cent digitonin (see Appendix i), in a volume equal to that of the
mitochondrial suspension, is added.

This suspension is incubated

at 0°C for 20 minutes, then diluted with three volumes of cold
0.25 M sucrose or 0.3 M mannitol, and centrifuged for 10 minutes
at 9^500 x £.

The supernatant solution and the fluffy top layer

of the precipitate are decanted.

The solid precipitate consists

mainly of inner membrane-matrix complex.
q -IC e to g lu ta r a te

D ehydrogenase

Purified a-.ketoglutarate dehydrogenase was prepared from pig
heart muscle by the methods of Sanadi, Littlefield and Bock (58)•
Fresh pig heart (0.375 kg) is ground and homogenized for two
minutes with 0.03 M potassium phosphate buffer, pH 7*2, in a
Waring blender operating at full speed.
centrifuged at 2000 x
discarded.

This homogenate is then

for 30 minutes and the precipitate

The supernatant is adjusted to pH 5»b with dropwise

addition of 10 per cent acetic acid with continuous stirring.
This suspension is then centrifuged at 200 x _g for 20 minutes, the
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supernatant discarded, the precipitate washed in 75 mi of water
in a glass homogenizer, and recentrifuged for 10 minutes at i+Q00
x _g.

The precipitate is suspended in 25 ml of water and adjusted

to pH 7*0 with 1.0 N NaOH.

This suspension is then alternately

frozen and thawed four times, centrifuged for 20 minutes at
18,000 x £.

Solid ammonium acetate (38.5 g) are then added per

100 ml of supernatant fluid, the suspension stirred an additional
^5 minutes, and then centrifuged for ten minutes at 18,000 x
T h e precipitate is then dissolved in 2.5 ml of 0.02 M potassium

phosphate buffer, pH 7.2, dialyzed overnight against one liter of
the same buffer, and made 10

“5

M with respec;- to L-cysteine.

The

final product is approximately three ml of fairly clear creamcolored solution which is stored frozen at -18°C.

The recovery

of enzyme activity is about 10 per cent of total homogenate
activity with 200- to 250-fold purification.
Protein Determinations
Protein concentrations were measured by three different
methods.

The standard protein assay method used for these studies

was the Biuret method (59) with bovine serum albumin (Armour
Standard) as the protein standard.

To three 0.1-ml samples of

the protein preparation was added 0.1 ml of Triton-urea reagent
(see Appendix i) and water to a volume of 1.0 ml.

Biuret reagent

(b.5 ml) was added to two of the three tubes and 1+.5 ml of a 3
per cent sodium hydroxide solution was added to the third tube.
Standard protein references and mannitol-EDTA blanks were assayed
concurrently with the unknowns.

Samples were allowed to stand for
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at least thirty minutes to allow for maximum color development.
The o p t i c a l

d e n s ity

of
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(60) o f p r o t e i n c o n c e n t r a t i o n

as

fo llo w s :

Five ml of Reagent C, made up daily from 50 parts Reagent A
and one part Reagent B, was added to all tubes (see Appendix I for
preparation of reagents).
to each of three tubes.
of protein.

One ml of protein solution was added

The reagent blank contained water instead

Color was developed by the addition of 0.5 ml of

Folin-Ciocalteau phenol reagent (1.0 N with respect to culfuric
acid) to two of these tubes.

The third tube served as a color

blank, to which 0.5 ml of water was added rather than the FolinCiocalteau phenol reagent.

A protein standard, containing 100

(ig of bovine serum albumin (Armour Standard), was assayed
concurrently with the samples in the same manner.

Klett

colorimeter (equipped with a number 62 filter) readings of the
blanks were subtracted from both unknown and standard protein
solutions.

The linearity of this method is maintained between

10 jag and 150 pg of protein per ml of solution.
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For rapid determination of protein content of fractions
obtained daring Sephadex G-25 gel filtration of the a-keto acid
preparations the absorbancies at 260 nm and 280 nm were measured
with a Beckman Model DU-2 spectrophotometer, and the protein
concentrations calculated from these readings by the following
formula:
Protein ( m g / m l ) = 1.1*5 E280nm - 0.7k
w here
at

th e

and
in d ic a te d

s ig n ify
w a v e le n g th s

th e m o la r e x t i n c t i o n
(61).

of

th e

s o lu tio n

RESULTS
Determination of Conditions for Assay of g-Keto
Ac id Dehydrogenases
Prior to a kinetic evaluation of the more complex parameters
of the interactions of a-keto acids in mammalian liver, it was
necessary to establish baseline experimental conditions in order
to ensure that subsequent studies would be conducted under
standardized and optimal conditions.
decarboxylation of five

Since the enzymatic oxidative

g-keto acids (KIC, KMV, KIV, KG, Pyr)

was to be investigated, it was desirable to establish, as
completely as possible, the essential components of the assay
systems used to measure these enzyme activities.
The relationships between protein concentration and decarboxylase
activity using carboxyl-labeled a-keto acid substrates are shown
for a-ketoisovalerate (Figure 3)> a-ketoisocaproate (Figure 4),
g-keto-p-methylvalerate (Figure 5 ), pyruvate (Figure 6), a-ketoglutarate (Figure 7 ).

The production of ' 'COg from labeled a-keto

acids was found to be linear with enzyme concentration to at least

6.0 mg of tissue preparation lot the branched-chain a-keto acid
substrates and for a-ketoglutarate; pyruvate gave linearity to
about lf.0 mg protein.

Enzyme assays were conducted as described

in the legend, in the text and in the "Methods" section.
The

linear evolution of

Ik
CO 2 obtained with increasing time

of incubation at 30°C is illustrated for a-ketoisovalerate
33

Fig. 3 . -- Formation of CO^ from a-ketoisovalerate as a
function of protein concentration

The amounts of

produced from KIV-1-^C with varied amounts of

mitochondria or "supernatant" preparations was measured by the
assay as described in the Methods section.

14
CO^

Each reaction mixture

contained in a final volume of 1.0 ml, the following (in micromoles)
mannitol, 150; potassium phosphate buffer, pH 7*2, 33; NAD, 1.0;
Li^CoA, 0.6; MgCl2, 1.0; CaCl2, 1.0; Na 2C03, 1.0; l-ll+C-KIV, 2.0;
and the indicated amounts of enzyme preparation.

Mitochondria and

"supernatant" fractions are described in the Methods section.
assays were conducted at 30°C for 10 minutes.

All
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Fig. k. —

Formation of CO^ from a-ketoisocaproate as a

function of protein concentration

lip
The amounts of

CO^ produced from 1-

lip
C-a-ketoisocaproate during

a 10 minute incubation period were measured by the

lip
CO^ assay.

All reaction components and conditions are the same as those
stated for Fig. 3,- with the exception of a-keto acid substrate,
lip
2.0 jumoles of 1- C-KIC, 3500 cpm per micromole, were added to
each reaction mixture

8

/

mitochondria
LO

protein
• ' u"1'
.
ii

*rU_.

/•a
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Fig. 5* ““ Formation of CO^ from a-keto-p-methylvalerate
is a function of protein concentration

"igure 5 shows the relative amounts of

Ik
CO^ produced from carboxyl-

Labeled KMV with varied amounts of the same washed preparation of
povine liver mitochondria.

The basic reaction mixture and assay

procedures were as described in Figure 3 with the exception of
substrate.

2.0 |jmoles of carboxyl-labeled KMV (2050 cpm. per

nicromole) were used as substrate in each flask.

OJ

O

m
C)
o
E
o

o

c

1+0

Fig. 6 . -- Formation of CO^ from pyruvate as a function
of protein concentration

Figure 6 shows the relative amounts of

1 *+CO^ produced from carboxyl'

labeled KMV with varied amounts of the same washed preparation of
bovine liver mitochondria.

The basic reaction mixture and assay

procedures were as described in Figure 3> with the exception of
substrate.

1.0 pinole of 1-^C-pyruvate 53,600 cpm per pinole was

added to each reaction flask

In

mg

PR O TEIN

h2

Fig. 7 . —

Formation of CO^ from CH-ketoglutarate as a function

of protein concentration

The amounts of

II4
]k
C0o produced from a-ketoglutarate-l- C with

varied amounts of the same washed preparation of bovine liver
mitochondria are shown in Figure 7 •

The basic reaction mixture

and assay procedures were as described for Figure 3 , with the
exception of a-keto acid suostrate.

1.0 pinole of carboxyl-labeled-KG

(50,000 cpm per pmole) was added to each reaction flask.
were for 10 minutes

Incubations

nanomofes COg / minute

mg
protein

(Figure 8) , Ct-ketoisocaproate (Figure 9 ), a-keto-p-methylvalerate
(Figure 10), pyruvate (Figure 11), and Ct-ketoglutarate (Figure 12).
Some deviation from linearity with che longer incubation periods
was noted, and for this reason appropriate linearity determinations
were obtained with each set of experimental conditions preliminary
to actual quantitative kinetic study.
Rates of oxidative decarboxylation of KIV, KIC, KMV, KG and
pyruvate were measured at various pH values to determine the value
for optimal assay conditions.

The results of the effect of pH of

the reaction medium upon the rate of ^ P 0 o production with carboxyllabeled KIV, KMV and KIC as substrates are shown in Figure 13 .
observed activity maxima were nearly identical.

The

Maximal reaction

rates with a-ketoglutarate and pyruvate were obtained at slightly
lower pH values.

The optimum pH for enzyme reaction with these

substrates is observed to lie in a range of 6.8 to "J.1 for bovine
liver mitochondria preparations.

A pH value of 7'2 was chosen

for all subsequent assays, since at this hydrogen ion concentration
the rate of non-enzymatic decarboxylation was minimal and the
enzymic activity was satisfactory with each of the a-keto acid
substrates.
The coenzymes NAD', coenzyme A, TPP, FAD and lipoic acid have
been shown to be essential in the oxidation of pyruvate and aketoglutarate by their respective enzyme complexes

(8, 9 , 62, 63, 64).

Table I shows the relative effect of these and several other
cofactors on the decarooxylation of a-ketoisocaproate by washed
preparations of bovine-liver mitochondria.

The activity of the

TABLE 1
EFFECTS OF SEVERAL COFACTORS ON a-KETOISOCAPROATE
DEHYDROGENASE REACTION3

Reaction medium

Relative activity

(per cent)
Complete-----------

100.0

minus N A D ----------------

11.7

minus CoA-----------------

8.6

minus MgCl^----------------

69*0

minus CaCl^-”-- ------------

12.0

minus NAD”1", plus 0.5
micromole NADP+--------

8.3

plus 0.05 praole lipoate---

103.0

plus 0.5 pinole TPP--------

92.6

plus 2.0 pmoles of ATP----

29«0

plus 0.005 pinole of FAD---

95.0

plus 0.005 pinole of FMN----

89*0

plus 1.0 pmole of CdCl^---

2.3

a
lii
KIG dehydrogenase activity was measured with the
C0 9 assay as
described in the Methods.
*
^The complete reaction mixture contained in a final volume of 1.0
ml, the following, in pmoles: mannitol, 150 ; potassium
phosphate buffer, pH 7*2, 33; NAD, 1.0; LioCoA, 0.6; MgClp, 1.0;
CaCl-^, 1.0; Na2C02, 1.0; 1-^+C-KIC, 2.0; and 0.1 ml of a washed
preparation of bovine liver mitochondria.
Subtractions from or
additions to the complete media were as indicated in the Table.

Fig. 8. —

Formation of CO^ from a-ketoisovalerate as a

function of incubation time

a-Ketoisovalerate dehydrogenase activity was measured by the
assay as described in the Methods section.

11+

CO^

Each reaction mixture

contained in a final volume of 1.0 ml the following (in micromoles)
mannitol, 150; potassium phosphate buffer, pH 7.2, 33; NAD, 1.0;
Li^CoA, 0.6; MgCl2 , 1.0; CaCl2, 1.0; Na 2C0^, 1.0; 0.1 ml of a
washed preparation of bovine liver mitochondria, and 2.0 micromoles
of l-'*' C-KIV (3700 cPm Per micromole).
at 30°C.

All assays were conducted

•J=-•3
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Fig. 9 . —

Formation of CO^ from a-ketoisocaproate as a

function of incubation time

Figure 9 shows the amounts of ^C-C^ evolved after various incubation
times at 30°C from 1-^C-KIC.

Each reaction mixture contained 0.1

ml of a washed preparation of bovine liver mitochondria, and 2.0
pmoles of 1-

Ik
.
.
C-KIC (3500 cpm per pinole).

All other components

of the reaction mixture, conditions, and assay procedures were
identical with those described in Figure 8.

•fr

m 3
•"ia*L

ilgl
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Fig. 10. -- Formation of CO^ from a-keto-(3-methylvalerate
as a function of incubation time

Figure 10 shows the amounts of

ill
CO^ evolved after various incubation

times at 30°C from carboxyl-labeled ^C-KMV (2050 cpm per pinole).
Each reaction mixture contained 0.1 ml of a washed preparation of
bovine liver mitochondria, and 2.0 pmoles of

Ik
C-KMV.

All other

conditions, reaction mixture components, and assay procedures were
identical with those described in Figure 8.
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Fig. 11. -- Formation of CO^ from pyruvate as a function
of incubation time

The amounts of

lU

CO^ evolved after various incubation times

1|

at 30 C from 1Figure 11.

C-pyruvate (58,600 cpm per pmole) are shown in

Each reaction mixture contained 0.05 ml of a washed

preparation of bovine liver mitochondria, and 1.0 pinole of 1-

14

C-pyr.

All other conditions, reaction components, and assay procedures were
as stated for Figure 8.

nanomoles CO2 / mg PROlEIN

00

\J1

Fig. 12. -- Formation of CO^ from a-ketogluterate as a function
of incubation time

Figure 12 shows the amounts of

llj.
CC^ evolved after various incubation

times at 30°C from a-ketoglutarate-l-^C (50,000 cpm per pinole).

Each

reaction mixture contained 0.05 ml of a washed preparation of bovine
liver mitochondria, and 1.0 pinole of 1-

14
C-KG.

All other conditions,

reaction components, and assay procedures were as stated for Figure 8.

so

Fig. 13 . -- The relationship between pH and branched-chain
a-keto acid dehydrogenase activities of bovine liver mitochondria

Assays were conducted at the pH values indicated in the Figure 13 .
Q-Keto acid dehydrogenase activities were measured with the
assay.

life
COg

Other reaction components were as stated in the legend

of Figure 3 with the exception of a-keto acid substrate.
a-keto acid concentration in each assay was 2.0 mM.

Initial

Phosphate

buffers were used throughout the entire range even though some
buffering capacity is sacrificed at the low and high pH values.

( A --- A

) KIV, ( g — H

) KMV, ( $ --- @

) KIC.
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mitochondrial enzyme which catalyzes this reaction is largely
dependent upon the presence of added NAD"1 and coenzyme A.

Other

components of the standard assay medium which appear to promote

+2 , Ca +2 and inorganic phosphate.

optimal reaction rates are Mg
effects of

The

are shown in a later figure, and the importance of

these agents will be discussed in more detail below.

Attempts to

demonstrate a direct stoichiometric relationship between reduction
of NAD+ and a-keto acid decarboxylacion have been thwarted by the
generally high degree of opacity (at 3^0 nm) of reaction mixtures
containing the particulate enzyme preparations, and by the variance
of reoxidation of NADH by the crude preparations.

Data of Table 1,

however, support the earlier postulation, as outlined above
(equations 2-7), that all of the components of the presumed
dehydrogenase complex participate in the overall oxidative
decarboxylation of the branched-chain a-keto acids by mammalian
-f

liver mitochondria.

It is apparent that NADP

can not replace

NAD+ as an electron acceptor in this reaction system.

Addition of

other presumptive cofactors such as TPP, lipoate and flavin
derivatives produced no significant effect upon KIC oxidation.
However, stimulation of the enzyme activity by these coenzymes would
not be expected in consideration of the generally tightly-bound
nature of these prosthetic groups with their protein apoenzyme
moieties.

Separation into free coenzyme and inactive apoenzyme

usually requires rather rigorous physical or chemical procedures.
These findings are in general agreement with those previously
reported for the oxidation of KIV by extracts of B. subtilus (10)
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and for the decarboxylation of KIC by isolated rat liver
mitochondria (11).

v "-,.

:>*,'■

An observation which was not entirely expected was that of
the marked reduction of catalytic activity in the presence of ATP
(2 mM).

This apparent inhibitory effect and the stimulatory nature

of inorganic phosphate in this system will be discussed in connection
with the possible existence of a kinase-phosphataie activating and
■
’

' :A..

de-activating system for the a-keto acid dehydrogenase complexes.
The results of a more thorough investigation of the effects of
CoA and NAD

+

on the branched-chain a-keto acid dehydrogenase

activities are shown in Figure 14 (KIC) and Figure 15 (KIV).

These

requirements (with those for KMV oxidation) are summarized in
Table 2.

These data indicate that both NAD

+

and CoA are essential

to maintain maximal branched-chain a-keto acid oxidative capacity
with washed preparations of mitochondria.

On the other hand,

decarboxylase activity of the supernatant fluid of tne 80,000 x g
centrifugation procedure (preparation of enzyme, see "Methods")
showed no apparent dependence on added CoA in the reaction medium.
The existence of an acyl-CoA hydrolase in the soluble fraction,
similar to that demonstrated by Namba e_t al. (10) in B. subtilus
preparations, conceivably could lessen the apparent need for
exogenous CoA by allowing for the continued regeneration of
catalytic amounts of the free coenzyme from acyl-CoA compounds
present as contaminants in the enzyme preparation.
A second possibility, which can not be excluded at present, is
that the supernatant fluid may contain a decarboxylase specific for
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TABLE 2
EFFECTS OF ADDED NAD+ AND CoA ON BRANCHED-CHAIN a-KETO
ACID DEHYDROGENASE ACTIVITIES OF MITOCHONDRIA AND
SUPERNATANT FRACTIONS OF BOVINE LIVER3

Reac tion mixture
Enzyme preparation
complete k

- CoA

- NAD+

- NAD+
- CoA

(nanomoles COg/min/mg protein)
a-Ketoisocaproate
dehydrogenase:
mitochondria--

1.7^

0.16

0.26

0.06

supernatant---

0.11

0.12

0.05

0.05

mitochondria--

3.20

0.29

0.39

0.11+

supernatant---

0.2Q

0.23

0 .17

0.13

mitochondria--

5.63

0 .1+7

0.66

0.39

supernatant---

0.03

0.03

0.01

0.01

a-Keto-p-methylvalerate
dehydrogenase:

OJ-Ke to iso vale rate
dehydrogenase:

cl
Braached-chaia a-keto acid dehydrogenase activity was measured
with the ^ C O ^ assay as described in the Methods.
The complete reaction mixture contained the following components,
in a final volume of one ml, in ^moles: mannitol, 150; potassium
phosphate buffer, pH 7.2, 33> N A D , 1.0; Li^CoA, 0.6; MgCl2 , 1.0;
CaCl 2, 1.0; Na 2C0 o, 1.0; 0.1 ml of enzyme preparation and 2.0
pmoles of carboxyl-labeled a-keto acid. Subtractions from the
complete media were as indicated in the Table.

Fig. 14. -- Effects of added NAD and CoA upon a-ketoisocaproate oxidation

KIC dehydrogenase activity was measured by the ^ C 0 2 assay as
described in the Methods section.

Each reaction mixture contained

in a final volume of 1.0 ml, the following constituents (in
micromoles):

mannitol, 150; potassium phosphate buffer, pH 7*2,

335 MgCl2, 1.0; CaCl2, 1.0; Nfi^CO^ 1.0; l-ll+C-KIC, 2.0 (36OO
cpm per micromole); 0.1 ml of a washed preparation of bovine liver
mitochondria (2.4 mg protein), or 0.2 ml of bovine liver "supernatant"
fraction (2.1 mg protein); 0.6 micromole Li^CoA, and 1.0 micromole
NAD where indicated.

The "supernatant" fraction referred to is the

supernatant of the 80,000 x

centrifuge spin as described in the

Methods section under "enzyme preparations'1.
to proceed for 10 minutes at 30°C*

Reactions were allowed
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Fig. 15 . —

Effect of added NAD and CoA on the rate of CC^

production from a-ketoisovalerate by bovine liver mitochondria

KIV dehydrogenase activity was measured by the
described in the Methods.

assay as

Additions of NAD, CoA and enzyme

preparations were as stated for Figure lb,

Each reaction mixture

contained 2.0 pmoles of 1-^C-KIV (3700 cPm Per nmole).

All ( her

conditions, reaction components, and assay procedures were as
stated for Figure l!+.
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the branched-chain a-keto acids, which does not require coenzyme A
as a component of its catalytic process.

The data of Table 2 also

disclose that the supernatant enzyme activity is significantly
higher with KMV and KIC as substrates, than for KIV.

This

represents a decided variance from the activity ratios observed
for the mitochondrial enzyme activities, where the rate of
decarboxylation was greatest with KIV as the a-keto acid substrate.
The following studies were initiated in an attempt to
elucidate to what extent the rate of branched-chain a-keto acid
decarboxylation was affected by varied concentrations of NAD+ and CoA.
The effects on evoluti- i of
studied in detail.

Ik
CO^ from carboxyl-label c KIC were

An apparent Michaelis constant for NAD+ of

3.2 x 10 “5 M was calculated from the reciprocal plots shown in
Figure 16 .

The Lineweaver-Burk plot in Figure 1J illustrates the

rfect of varied CoA concentrations on KIC oxidation by bovine liver
mitochondria.

Apparent inhibition by CoA was observed with
-q

concentrations above 10

M, with a calculated K value for
m

coenzyme A of 6.*4 x 10 ^ M.
Preliminary observations by this author and prior investigation
by Hayakawa (65), Lusty and Singer (55) and Wohlheuter (ll) had
indicated that the divalent cations Ca^+ , Mg^+ and sometimes Mn^+
appeared to modify significantly the a-keto acid dehydrogenase
activities.

These effects were noted with purified enzyme

preparations and with suspensions of mitochondria.

Requirements

of the branched-chain a-keto acid dehydrogenases for certain divalent
cations are shown in Table 3*

The dehydrogenase activities with

each of the three branched-chain a-keto acids was strongly stimulated
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TABLE 3
EFFECTS OF ADDED MgCl^ CaCl2 AND MnCl2 IN THE REACTION MEDIUM
ON THE BRANCHED-CHAIN a-KETO ACID DEHYDROGENASE ACTIVITIES
OF BOVINE LIVER MITOCHONDRIA PREPARATIONS3

Enzyme and additions

specific activity

relative activity

(nanomoles/min/mg protein)

(per cent)

Ct-Ke to is ocapro ate
dehydrogenase:
Ca"2
Ca"'
+2
Ca_
c*' ,

Mg+2..... —

-

2.72

1.88

”“+2.........

100
69

Mg

0.1 6

6

+2
Mg %

Mn+2
Mn

0.13
2.56

+2

^|n+2

5
94
82
7
4

-

none------ --- — —

2.24

0.18
0.11

a-Ke to iso valerate
dehydrogenase:
Ca+§, „ g+2........ .
Ca

""“”+2........ .
Mg --------none------ --------

3.40
2.51
0.35
0.21

100

3.31
2.46
0.29

100

74
11

6

a-Keto-3 -methylvalerate
dehydrogenase:
Ca^2; Mg+2........ .
Ca^ - ;Mg
■ + § --------........ .
none---- ----------

0.16
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Branched-chain a-keto acid dehydrogenase activity was measured
with the 1 ;C0? assay as described in the Methods,
b
^
Each reaction mixture contained the following, in pmoles;
mannitol, 150; NAD, 1.0; Li-XoA, 0.6; Na2CCo., 1.0; carboxyllabeled a-keto acid, 2.0; 07*1 ml of a washed preparation of
bovine liver mitochondria, and 1.0 pinole of each divalent cation
where indicated, in a final volume of 1.0 ml.
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Fig. 16. -- Lineweaver-Burk plot of KIC dehydrogenase activity
as a function of NAD+ concentration

Lineweaver-Burk plots of
as varied coenzyme.

Ik
lk
+
CO^ evolution from 1- C-KIC with NAD

KIC dehydrogenase activity was measured by

+
lU
the NAD - and CoASH-dependent
CO^ assay as described in the Methods
section.

Each reaction mixture contained the following (in pmoles):

mannitol, 150; potassium phosphate buffer, pH 7*2, 33i Li^CoA, 0.6;
MgCl^, 1.0; Ca/Jl^, 1.0; Na^CO^ 1.0; the indicated amounts of
NAD , and 0.1 ml of mitochondria suspension in a final volume of
1.0 ml.

(v^, nanomoles of CO^ produced per minute per mg of protein).
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Fig. 17 . -- Lineweaver-Burk plot of the activity of a-ketoiso
caproate dehydrogenase activity as a function of CoA concentration

KIC dehydrogenase activity was measured by the

Ik
CO^ assay.

All

components of the reaction medium were the same as for Figure 16,
except that 1.0 pinole of NAD was used^ and CoA concentration was
varied as indicated in this Figure.
per minute per mg of protein).

(v^

nanomoles COg produced
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by added Ca^+ ; and to a lesser extent by exogenous M g ^ '.
effects of Mg

The

2+ and Ca 2+ appear to be, additive, suggesting that

the activation by these two cations occurs by separate mechanisms.
2+
In this regard It should be noted that An
could apparently
replace the Mg

24-

substitute for Ca

requirement to a limited extent, but could not
24

. The relative rates of oxidation of KIC, KMV

and KIV were decreased by nearly identical amounts when exogenous
Mg

24

, Ca

2+

or both cations were omitted from the reaction medium.

The effects of other divalent cations were not studied
systematically.

,2 4

However,- it was observed that 1.0 mM Cd

completely

inhibited KIC decarboxylation.
The striking dependence of (branched-chain a-keto acid)
oxidative decarboxylation on Ca
further study of their effects.

24

and inorganic phosphate prompted
Reciprocal plots illustrative of

the influence of varying amounts of added Ca
(Figure 19) are included.

(Figure 18) and P.

The exact nature of the non-linearity

of these plots is not understood at this time.

Apparent affinity

constants of the order 1.0 mM for Ca^+ and 20 mM for P. can be

1

estimated from these plots.

It is of some general interest to note

that these values approach the physiological levels found for Ca

42

in mammalian liver mitochondria (66 ,67 ) and those calculated
for inorganic phosphate in whole liver homogenates (68,,69)*
All CH-keto acid dehydrogenase assays to be described in the
following studies were conducted under the optimal conditions
based on the information reported above:

1.0 mM NAD+ , 0.6 mM CoA;

1.0 mM CaCl^; 1.0 mM MgCl^; and 33 mM potassium phosphate buffer,
pH J.2,

Reaction incubations were carried out at 30°C for an

•/ ■

v-

■
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Fig. 18. -- Effects of added CaCl

on the KIV dehydrogenase

activity of bovine liver mitochondria

Lineweaver-Burk and Michaelis-Menten plots of the effects of varied
Ca

+2

concentration on evolution of

in Figure 18.

KIV dehydrogenase activity was measured by the

assay as described in the Methods.
pinoles) :

ll}14
CO^, from 1- C-KIV are shown
2

Reaction mixtures contained (in

mannitol, 150; potassium phosphate buffer, pH 7*2, 33> NAD,

1.0; Li^CoA, 0.6; MgCl2, 1.0; Na^O^, 1.0; 1-11+C-KIV (3500 cpm per
pinole), 2.0; 0.1 ml of a washed preparation of bovine liver
mitochondria, and the indicated amounts of CaCl2 in a final volume
of 1.0 ml.

(v^, nanomoles C02 produced per minute per mg of protein)

;.w

rt;>

£L
^ fe& fciSr i - M
.:. : # i ;'*vA,%;••ssSfc*,; £•.'

*i:,v •*&%£&&&;%;.•■»-•".;;«'iT y& k yI;•<,‘^ * - '%*,*••

Fig. 19 . —

Effect of changes in orthophosphate concentration

on the KIV dehydrogenase activity of bovine liver mitochondria

Lineweaver-Burk and Michaelis-Menten plots of the effects of
varied

concentration on evolution of

shown in Figure 19 .

Ilf
Ilf
CO ^ from 1- C-KIV are

Reaction mixtures, experimental conditions,

and assay procedures were as stated for Figure 18, except that P_^
concentrations were varied, and 0.01 M triethanolamine hydrochloride,
pH 7.2, was used to maintain buffering capacity, and 1.0 pinole of
CaCl„ was added to each reaction flask,
2
per mg protein).

(v., nanomoles per minute
N 1’

4
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appropriate time interval dependent upon the extent of linearity
obtained for the particular set of experimental conditions of
the investigation.

Any variation from these conditions is noted

in the legend of tables and figures, or in the text.
Effeets of a-Keto Ac id Substrate Concentration on ■-Keto
Acid D e h y d r o g e n a s e R e a c t i o n R a t e s
Quantitative studies of the influence of substrate
concentration upon the rate of oxidation of the a-keto acids were
essential as a prerequisite to the investigation of mutual metabolic
interactions among these compounds.

Apparent K values were
m

determined for KIV, KMV, KIC, KG and pyruvate.

Substrate effects

were investigated over at least a ten-fold variation of concentration
for each keto acid.

The relationship between the reciprocal of

initial reaction velocity (v ) and the inverse of KIC concentration
is shown in the Lineweaver-Burk plot of Figure 20.

The apparent K
m

value for KIV calculated from these plots was 0.33 niM.

The

information represented by the reciprocal plots of Figure 21
allows for determination of the apparent K for KMV, which is
m
0.^7 mM.

A Michaelis constant of 0.44 mM is obtained for KIC from

the data illustrated by Figure 22.

The experimental results which

are included in double reciprocal ferm in Figure 23 show the
apparently linear double reciprocal plots determined by variation
of c-ketoglutarate concentration between 0.05 mM and 1.0 mM.

It

should be mentioned that significant deviation from linearity was
observed at KG concentrations below 0.04 mM.

This phenomenon may

be due to the existence of the presumed permeability barrier to KG
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Fig. 20. —

Effect of varied a:-ketoisovalerate concentration

on the rate of CO^ production by bovine liver mitochondria

Lineweaver-Burk plot of the activity of KIV dehydrogenase of bovine
liver mitochondria as a function of substrate (KIV) concentration
(v^, nanomoles of CO^ produced per minute per milligram of protein).
Enzym e
M e th o d s

a c tiv ity
se c tio n .

was m e a s u r e d w it h
Each

th e

lii

r e a c t io n m ix tu r e

CC^ a s s a y
c o n ta in e d ,

of 1.0 ml, the following (in micromoles):

as
in

d e scrib e d
a fin a l

in

the

vo lu m e

mannitol, 150 ; potassium

phosphate buffer, pH 7.2, 33; NAD+ , 1.0; Li^CoA, 0.6; MgCl,,, 1.0;
CaCl^, 1.0; Na^CO^., 1.0; 0.1 ml of a washed preparation of bovine
1

er mitochondria (about 2.5 mg of protein), and the indicated amounts

or 1"

12+
.
.
C-KIV (3700 cpm per micromole).

proceed for 20 minutes at 30°C.

Reactions were allowed to

2.Or
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Fig. 21. -- Effect of varied a-keto-|3-methylvalerate
concentration on the rate of formation of CO^ by bovine liver
mitochondria

Linewsaver-Burk plot of the activity of KMV dehydrogenase of bovine
liver mitochondria as a function of substrate (KMV) concentration
(v ^

nanomoles of CO^ produced per minute per mg of protein).

Each

reaction mixture contained 0.1 ml of a washed preparation of
mitochondria and the indicated quantities of carboxyl-labeled KMV.
All other experimental conditions, reaction components and assay
procedures were as stated for Figure 20.

$

0.6
V,

:

-*;V

m-

>v%;•
:
■i.‘VV,-

..*‘
F ••
’111!

»*
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Fig. 22. -- Effect of varied a-ketoisocaproate concentrations
on the rate of CC^ production by bovine liver mitochondria

Lineweaver-Burk plot of the activity of K I C dehydrogenase of
bovine liver mitochondria as a function of substrate ( K I C )
concentration (v^, nanomoles of CC^ produced per minute per mg of
protein).

Each reaction mixture contained 0.1 ml of a washed

preparation of mitochondria and the indicated quantities of
1-^C-KIC (3500 cpm per jjmole) .

All other experimental conditions,

reaction components and assay procedures were as stated for Figure 20.

■ ;:& , k?'•>'*!Xp$.
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Fig, 23. —

Effect of varied o-ketoglutarate concentration

on the rate of formation of CO^ by bovine liver mitochondria

Lineweaver-Burk and Michaelis-Menten plots of the activity of CLketoglutarate dehydrogenase of bovine liver mitochondria as a
function of substrate (KG) concentration (v^, nanomoles of CO^
produced per minute per mg of protein).

Each reaction mixture

contained 0.05 ml of a washed preparation of mitochondria and the
indicated quantities of 1-

II4
C-KG (50,000 cpm per pmole).

were allowed to proceed for 10 minutes at 30°C.

Reactions

All other

experimental conditions, reaction components and assay procedures
were as stated for Figure 20.
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or the offects of a translocase at the inner membrane, since this
phenomenon was also observed when washed preparations of rat liver
mitochondria served as the source of enzyme, but was not evident
with the purified KG dehydrogenase from pig heart muscle.

A K
m

value of 0.08 mM KG was calculated from the data illustrated in
The inverse plots shown in Figure 2k allow a K value
m

Figure 23*

of 0.22 mM for pyruvate to be computed.

The apparent K values
m

obtained from the average of several determinations are summarized
in Table U.

Inhibition by KIC concentrations in excess of 2.0 mM

was noted, while no substrate inhibition of the decarboxylase
activity by concentrations of KIV to 10 mM was found.

None of the

other a-keto acids exhibited this characteristic (substrate
inhibition) within the ranges of concentration utilized for these
studies.

The true Michaelis constants can not be determined easily

for these reactions by the methods of Florini and Vestling (70),
since at least three substrates (NAD', CoA, a-keto acid), and
perhaps additional cofactors, participate in the tightly coupled
enzyme reaction sequences of the a-keto acid dehydrogenase complexes.
Subcellular Distribution of Bovine Liver Branched-Chain
a-Keto Acid Dehydrogenase Activities
Among the principal objectives of this entire study was the
elucidation of the cellular localization of the branched-chain
keto acid dehydrogenase activities.

This was desirable for at

least two reasons, first to obtain the highest specific enzyme
activity fraction for the succeeding studies, and second, to
accumulate additional information with respect to the number of
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TABL , 4

K VALUES FOR SEVERAL a-KETO ACID DEHYDROGENASES OF
m
BOVINE LIVER MITOCHONDRIA

CC-Keto Acid Substrate

a,

K (moles liter 1)
m

a - K e t o i s o v a l e r a t e ------------

3 .3

± 0.4

10 "^

(5)

a - K e t o i s o c a p r o a t e - - -------

5.2

± 0.6

io"u

(4)

a -K e to -p -m e th y lv a le r a te

4.7

± 0.8

io

Pyruvate---- ---- -

2 .4

± 0.2

lo"^

(5)

1 0 _i|

(4)

—

a - K e t o g i u t a r a t e --------- -—

0.81 ± 0.09

"11

(4)

a
14
Carboxyl-labeled
C-QJ-keto acids were used as substrates for the
measurement of the enzyme activities by the -^CO evolution assay
as described in the text and in the Methods section.
j_

Kjh values tabulated are the mean ± one standard deviation for the
number of determinations indicated in parentheses.
Each reaction mixture contained the following in pmoles:
mannitol, 150; potassium phosphate buffer, pH 7*2, 33s NAD, 1.0;
Li3CoA, 0 .6 ; Mgci2 , 1.0; CaCl2, 1.0; Na2C03, 1.0; 0.05 or 0.1
ml of a washed preparation of bovine liver mitochondria, and
appropriate amounts of carboxyl-labeled a-keto acids.
Determinations were conducted at 30°C.

87

Fig. 2k. -- Effect of varied pyruvate concentration on the
rate of formation of CO^ by bovine liver mitochondria

Lineweaver-Burk plot of the activity of pyruvate dehydrogenase of
bovine liver mitochondria as a function of pyruvate concentration
(v^, nanomoles CO^ produced per minute per mg of protein).

Each

reaction mixture contained 0.05 rob of a washed preparation of
mitochondria and the indicated amounts of 1pinole).

lU
C-Pyr (58,000 cpm per

Reactions were allowed to proceed for 10 minutes at 30°C*

All other experimental conditions, reaction components, and assay
procedures were as stated for Figure 20.
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3.0

PYRUVATE

x 10 3 M '1

39

branehed-chain keto acid dehydrogenase enzymes in the bovine liver
cell.

Figure

25

g ives

general indication of the relative levels

a

of KIC dehydrogenase activity in various bovine liver tissue
preparations obtained by the centrifugation techniques described
in

the " M e t n o d s " section.

Table 5

shows the distribution of each

branched-chain a-keto acid dehydrogenase activity in these
subcellular fractions.

Succinate dehydrogenase (EC 1.3*99»1») was

employed as a mitochondrial marker enzyme (kty), and glucose-6 phosphatase

(pi).

(EC 3 * 1 » 3»9-)

served to identify the microsome fraction

The major portion of the a-keto acid dehydrogenase activity
llj.

at measured by

COj production from carboxyl-labeled substrates

was found in the fraction which contained the mitochondria.

The

origin of the smaller amounts of activity located in the supernatant
(soluble) fraction is in doubt, since some of the characteristics
of: this activity appear to differ from those of the mitochondrial
branched-chain a-keto acid dehydrogenase.

The ratios of activity

with KIV, KMY and KIC are different, and dissimilar coenzyme
requirements were noted (see Table 2).

These distinctive features

will receive further comment in the "Discussion".

Minor amounts of

activity observed in the nuclear ana microsome fractions likely
result from some slight contamination with mitochondria.
Localization of q-Keto Acid Dehydrogenase Activities with
Respect to the Mitochondrial Inner Membrane
Knowledge of the intra-mitochondrial location of the enzymes
responsible for the catalysis of oxidative decarboxylation of KIC,
KMV, KIV, pyruvate and a-ketoglutarate in bovine liver cells is of
considerable general interest, and could contribute to an understanding

TABLE 5
S U B C E L L U L A R D I S T R I B U T I O N OF
Q-KETO ACID

Fraction

BOVINE LIVER

DEHYDROGENASE

a-ketoisovalerate
dehydrogenase

a-ketoisocaproate
dehydrogenase

a - k e t o - p - m e t h y 1valerate
dehydrogenase

io h omo-

% homo

specific
activity

°J0 h o m o 
genate

specific
activity

genate c

specific
activity

genate

BRANCHED-CHAIN

succ i n a t e
dehydrogenase

glucose-6phosphatase

•jo h o m o  s p e c i f i c °j0 h o m o  spec ific
genate

activity

genate

activity

*

N u c l e a r ---------

8.0

0.24

6. l

0.16

9.3

0.21

8.7

0.56

N.D.

N.D.

M i t o c h o n d r i a ---

88.2

5-54

86.8

2.98

88.7

3.51

84.6

3 .6 0

0 .7 2

0.002

2.1

0.05

0.8

0.02

0.9

0.02

5*3

0.18

1-7

0 .0 6

2.k

0 .1 7

3.2

0 .%

1. 8

0 .0 6

S o l u b l e ---------

%

recovery
N.D.

95.3

N.D.

0.212
N.D.

N.D.

100.4

99-3

98.9

8 3 .2

= not d e t e r m i n e d

S u b c e l l u l a r f r a c t i o n s w e r e p r e p a r e d as d e s c r i b e d i n t h e M e t h o d s

h)

section.

^)j

CC-Keto a c i d d e h y d r o g e n a s e

activities were measured with

the

COp

(NAD,

S u c c i n a t e d e h y d r o g e n a s e a c t i v i t y w a s d e t e r m i n e d b y t he m e t h o d o f B o n n e r
b y the m o d i f i e d m e t h o d of N o r d l i e a n d A r i o n (51) ( s e e a l s o M e t h o d s ) .

Co A )

assay

(49) > a n d

(s e e M e t h o d s ) .
glucose-6-phosphatase

Q

P e r cent h o m o g e n a t e r e f e r s to the a m o u n t of a c t i v i t y
for that s u b s t r a t e in the w h o l e h o m o g e n a t e .
dDigitonin solubilization treatment
dehydrogenase

established

the

(57)

present

(see a l s o M e t h o d s )

inner membrane-matrix

as

t he

in a fraction compared

to

the

total

activity

followed

by assays

for b r a n c h e d - c h a i n a-keto

location

for these

enzyme

activities.

\
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Fig.

25.

dehydrogenase

The amounts of

C o m p a r i s o n of r e l a t i v e
in v a r i o u s b o v i n e

liver

Ik

specific

subcellular

CO^ produced from 1-

a c t i v i t y of KIC
fractions

Ik

C-KIC during incubation with

varying amounts of the indicated subcellular fractions of bovine
liver was measured by the
section.

Ik
C0 2 assay as described in the Methods

The fractions were prepared as stated in Methods.

Each reaction mixture contained in a final volume of 1.0 ml, the
following (in micromoles):

mannitol, 150 ; potassium phosphate buffer,

pH 7.2, 33; NAD+ , 1.0; Li^CoA, 0.6, MgCl2, 1.0; CaCl2, 1.0; N a ^ O ^
the indicated amounts of enzyme preparation, and 2.0 micromole of
l-^C-KIC (3700 cpm Per micromole).
proceed for 20 minutes at 30°C.

All reactions were allowed to

1.0;

mitochondria
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of the relationships among these metabolites.

Information about the

spatial arrangement of these enzymes with respect to the inner
membrane would provide some clarification of the question of whether
the a-keto acid substrates must penetrate to the matrix prior to
oxidation (see footnote d on Table 5)*

It is generally accepted

that the outer membrane of isolated mitochondria is freely
permeable to substances of low molecular weight (7 l,72 ,73 >7 *+) > in
contrast to the apparent selective permeability toward small
molecules and charged ions characteristically exhibited by the
inner membrane (50,52,75)*

Nucleotide derivatives such as NAD+

(52,71), CoA (76 ) and most substrates which permeate the intramembranal space ( 10 ,7 ^+) do not readily penetrate the inner membrane.
Klingenberg (50) and Mitchell (75 ) have provided direct evidence
that the artificial electron acceptor ferricyanide does not
penetrate the intact inner membrane.

This agent has subsequently

been used by several investigators to determine whether an enzyme
which can reduce ferricyanide in the presence of its substrate(s)
is located on the outer side or on the matrix side of the inner
membrane (see "Methods" for a further discussion of this technique).
A major site of ferricyanide reduction by mitochondrial preparations
is at cytochrome c (50).

Antimycin A, an inhibitor of respiration,

is known to block electron transport between reductants inside the
mitochondria through ubiquinone and cytochrome c to the non
penetrant ferricyanide which acts as electron acceptor (52).

The

"ferricyanide method" of enzyme localization is therefore based
upon the inability of ferricyanide to react directly with those

enzymes facing coward the matrix or located in the matrical mileu.
The relative ability of a substrate to reduce ferricyanide in the
presence or absence of antimycin A will thus provide information
pertaining to the intra-organelle location of the enzyme active
site.

The compartmentation of several intramitochondrial enzymes

has been determined with this technique, among which are the aglycerophosphate dehydrogenase of rat liver and locust flight
muscle mitochondria (50) and the NADH dehydrogenase of yeast
mitochondria (7 1 ).

Figure 26 contains representations of actual

spectrophotometer recordings of the rate of reduction of
ferricyanide, as measured by the changes in absorbancy at 1+20 nm
in the presence of a number of substrates.

The results in this

figure and in Table 6 show that antimycin A considerably decreases
the transfer of electrons to ferricyanide cytochrome c with
succinate or a-ketoglutarate as substrate, and has some inhibitory
effect upon reduction with pyruvate.

Antimycin A causes

insignificant diminution of the rate of ferricyanide reduction with
a-glycerophosphate, KIC, KMV or KIV as the oxidizable substrate.
The results indicate that ferricyanide can apparently interact
directly with the enzymes catalyzing oxidation of the branchedchain a-keto acids, an observation which locates the sites of these
dehydrogenase activities on the outside of the inner membrane.
Such a situation obviates the need for these compounds to cross the
inner membrane for oxidation and appears to eliminate the need of a
specific translocase mechanism for KIC, KIV and KMV.

In contrast

to these activities, the observation that reduction of ferricyanide
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TABLE 6

SENSITIVITY OF FERRICYANIDE REDUCTION TO ANTIMYCIN A

Substrate

. . a
enzyme activity
( s ) , mM ______________________________
w/o antimycin

+ antimycin A

per cent
inhibition

± 0 .01+

0

0.200 + 0.003

0.006 ± 0.003

70

5.7

0.100 ± 0.01

o.oi+

Ct-Ketoglutarate

2.85

0.065 ± 0.01

0.010 ± 0.005

a-Ketoisocaproate

7-1

0.03

± 0.01

0.03

± 0.01

0

a-Keto-pmethylvalerate

5.7

0.05

± 0.01

0.05

± 0.01

0

a-Ketoisovalerate

7.1

0.05

± 0.01

0 .01+8 ± 0.005

a-Glycerol-P

5.7

0.20

Succinate

5.7

Pyruvate

+ 0.02

0.22

± 0.01

60
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1+

Enzyme activities were estimated by spectrophotometeric
measurement; of ferricyanide reduction in the presence of substrate,
at 1+20 nm on a Cary 15 recording spectrophotometer, as described
in detail in the Methods section. Antimycin A (2 pg/ml) was
added to assay mixtures where indicated.
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Fig. 26 . -- The accessibility of ferricyanide to several aketo acid dehydrogenases compared with its accessibility to succinate
dehydrogenase and a-glycerol-phosphate dehydrogenase

Spectropnotometric recording of ferricyanide reduction at 1+20 nm
catalyzed by bovine liver mitochondria with the indicated substrates
was measured as described in the Methods section.

Each reaction

mixture contained in a final volume of 3*5 ml, the following (in
micromoles):

mannitol, 525; potassium phosphate buffer, pH 7*2, 755

ATP, 3.0; ECTA, 3.5; MgSO^, 10; TPP, 2.5; K 3Fe(CN)£, 1.67; 0.1 ml of a
washed preparation of bovine liver mitochondria, and where indicated,
succinate, 20 micromoles; a-glycerophosphate, 20 (imoles; KIV, 25 pmoles;
KMV, 20 pinoles; KIV, 25 pmoles; KG, 10 (mmoles; or pyruvate, 20 micro
moles.
section.

Enzyme activities are calculated as described in the Methods

I min.

*
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in the presence of succinate or a-ketoglutarate is severely
limited by added antimycin A is in agreement with earlier evidence
supporting the supposition that the dehydrogenase enzymes for these
compounds are located on the inside face of the inner membrane or
in the matrix (77).

The observed ability of antimycin A to

partially inhibit the reduction of ferricyanide by pyruvate implies
that the pyruvate dehydrogenase complex also faces the inner
surface of the inner membrane.

The results with a-glycerol

phosphate agree with those obtained by Klingenberg (50), who
postulated that the mitochondrial a-glycerolphosphate dehydrogenase
faces the intermembranal space.
The relatively slow rate of penetration of the inner membrane
by the branched-chain a-keto acids is also inferred indirectly
from the recordings of the spectrophotometric absorbance of a
suspension of mitochondria in the presence of high concentration
of the sodium salt of ehe acid and a permeant cation (e_.£. NH^+ )
as an indicator of osmotic swelling (73)*
theoretical and experimental detail).

(See Methods for further

Figure 27 shows that the

inner membrane of bovine liver mitochondria is apparently less
permeable to the branched-chain a-keto acids (KIC, KMV. KIV) and
Ct-glycerolphosphate than toward acetate or inorganic phosphate.
The apparent existence of a permeability barrier to these a-keto
acids is reminiscent of that previously reported for a-ketoglutarate
with rat liver mitochondria (77.>78,79)-

These data also confirm

those of Klingenberg (50) for the low rate of permeation of a-GP
through the inner membrane of rat liver mitochondria.
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Fig. 27. —

Osmotic response of bovine liver mitochondria to

l-keto acids and other permeant anions

'urbidity was recorded after addition of mitochondria to an iso'•motic solution of various anions.

A decrease of absorption indicates

iwelling of mitochondria due to the uptake of anions and NH^+ .

addition of mitochondria (0.5 mg protein per ml) to a mixture of

:he following (in micromoles):

triethanolamine, pH 7*2, 155

fH^Cl, 755 and KIC, KMV, KIV, a-glycerol-P,

sodium phosphate or

iodium acetate, 7 5 ; in a final volume of 1.5 ml.

idjusted to pH 7*2 and 25°C prior to use.

All reagents were

Other experimental conditions

m d assay procedures were as described in the Methods.
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I min.
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Investigation into the Number of Branched-Chain q-Keto Acid
Dehydrogenases In Br .qe Liver Mitochondria
The ideal approach tu the question of enzyme specificity is to
isolate the enzyme, which then can be characterized with respect
to its ability to utilize a variety of substrates.

Attempts to

purify the branched-chain q-keto acid dehydrogenases from
mammalian liver have been largely unsuccessful (11,13).

A

considerable number of physical and chemical procedures were
utilized, with generally undesirable effects on the enzyme
activities (11,13).

Connelly, et_ al. (79) have reported a partial

purification of a semi-specific enzyme from bovine liver supernatant
fraction which was able to decarboxylate KMV and KICL

However, this

preparation appeared to be unstable to dilution, and thus was
unsuitable for extensive study.
Dixon and Webb (8l) present a kinetic approach, which can be
used when the physical separation of two or more enzyme activities
is not possible, useful for analysis of the question of whether
one or more dehydrogenases catalyze the oxidative decarboxylation
of the three branched-chain a-keto acids KIC, KMV and KIV.
According to the relationship shown in Equation 10 (below), if one
enzyme is involved in a semi-specific conversion of two substrates,
the observed rate of activity is dependent upon the affinity of
the enzyme for each of these substrates and thus upon the degree
of competition between these substrates for the common active center.
In this case, if A and B are the substrates, the rate of conversion
of A (v ) in the presence of B can be expressed by the equation;

Q.
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(8)

1

K

+

1

/ A

+

-^B- /

/

*b

and the rate of conversion of B (V^) in the presence of A is
expressed by;
V,

(9)
.

1

K,

+

b

1

+

Z a _/

/ B /

K

The total velocity (v ) of the reaction of the enzyme with varying
amounts of the substrates A and B may be denuted by the sum of
equations eight and nine.
v

v,t = av

+b v,
1

K & and

- A- / ,
— —
+
K,

a
+

v,
b

- B- ,/
K

/ A /

' B /

Ka

^

(10 )

refer to the respective Michaelis constants for A and B,

while V 5 and

are the maximal vel cities extrapolated at infinite

substrate concentration.

Equation 10 can be expressed in terms of

the relative concentrations, a = A/Ka, and 3 = B / ^ , in the
following manner if the two substrates are being attacked by the
same enzyme:
\t
( 1 -+ a)
ry ^
va
(1
+. \vK (1 + p)
l

j

(11)

vt

1

+

a

+

3

This equation is useful to calculate the theoretical total velocity
(v ) from a knowledge of the initial velocities (v
K

and v ) and the

value for each substrate, without having to compute the maximum
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velocity for each instance.

The results of a comparison of the

total velocities in the presence of each possible paired combination
of the keto acids, KIV, KIC, KMV, KG and Pyr are presented in Table
7.

The specific enzyme activity (v , observed) was determined for

each keto acid separately at two levels of substrate, and with the
indicated substrate combinations.

The columns headed v

a

+ v,
b

represent the summations of the individual keto acid activities
when present separately in the reaction mixture.

This additive

effect would be expected to result from the influence of two separate
enzymes catalyzing the conversion of the two substrates, and no
mutual inhibition.

The middle column under each substrate

concentration heading (vt> calculated) gives the values calculated
with the aid of Equation 11.

Thus, agreement between the observed

(vfc, observed) and the calculated (v , calculated) total velocities
is considered to be indicative of the participation of a single
enzyme.

The only exception to this pattern could occur for two

enzymes E_ and E^, where each is inhibited by the substrate of the
other enzymes, and then only in the incidental case where Kma for E^
is equal to K.- for E, and 1C,, for E, is equivalent to K.-, for E .
■*-a
b
™b
b
1b
a
The results of these combined substrate experiments, utilizing
the predetermined K value for each keto acid and initial velocitv
m
measurements for the substrates separately and in combination,
suggest the existence of a single enzyme complex catalyzing the
oxidative decarboxylation of KIC, KMV and KIV.

The data with

bovine liver mitochondria also indicate that pyruvate and a-ketoglutarate dehydrogenase activities are separate from those of the

io4

TABLE 7

RATES

OF D E C A R B O X Y L A T I O N OF KIV, K I C , KMV, Pyr A N D a - K G
I N D I V I D U A L L Y A N D C O M B I N E D 51

specific

Substrate

activity

(substrate)^

v

v
t

observed

C
t

(substrate)

v

+
a

calculated

V,
b

V
observed

K IV

4.38

5.55

KIC

3.08

M 9

KMV

3.57

4.66

KG

0.88

1 .9 6

Pyr

2.43

4 .0 1

5.26

5.39

7.^6

6.16

6.39

+ KMV

5.32

5.75

7.95

5.86

6.59

10 .2 1

9 .9b

KIC +

KMV

4.03

4 .9 0

6 .6 5

5.42

5.93

9.05

KIC +

Pyr

4.86

3.87

5.51

6.93

5.28

8 .4 o

+ Pyr

6.21

4 .6 9

6.21

7.42

5.89

9.56

KIV

V,
b

calculated

KIC

KIV +
KIV

+
a

KMV +

Pyr

5 .8 3

4.20

6.00

8.11

5.4-5

8 .6 7

K IV +

KG

4.97

3 .8 2

5.26

7.04

4.88

7.51

KIC + KC

3.64

2.85

3.96

5.88

4.07

6.35
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TABLE 7 —

Continued

specific activity
Substrate
(substrate)^
c
Vt
Vt
observed calculated

(substrate)^

V

a

+

V.

b

V

t
observed

c
v + vL
Vt
a
b
calculated

KMV + KG

i+.39

3.19

k.k$

6.13

k.23

6.62

KG + Pyr

3.17

2.39

3.31

5.^9

3.86

5.97

a-Ketp acid dehydrogenase activities were measured by quantitation of
the ^C02 produced from carboxyl-labeled a-keto acids in the presence
of NAD and CoA (see Methods for assay). Each assay mixture contained
the following, in |umoles: mannitol, 150 ; potassium phosphate buffer,
pH 7 .2 , 33; NAD, 1.0; Li_CoA, 0.6; MgClp, 1.0; CaCl2 , 1.0; Na COo,
1 .0 ; 0.05 or 0 .1 ml of a^washed preparation of bovine liver
mitochondria, and the indicated quantities of carboxyl-labeled aketo acids adjusted to equivalent specific activities, in a final
volume of 1.0 ml. All incubations were conducted at 30°C.
Two combinations of a-keto acid concentrations were used. (substrate)^
values for each keto acid, in nmoles; KIV, 0.25; KIC, 0.25; KMV,
0.25; KG, 0.05; Pyr, 0.10.
(substrate) 2 values, in jjmoles: KIV,
0.50; KIC, 0.50; KMV, 0.50; KG, 0.10; Pyr, 0.30.
Competitive interaction among substrates was assumed for these
calculations. This assumption is only partially correct for those
combinations in which a-ketoglutarate and a branched-chain a-keto
acids were paired.
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branched-chaia keto kc id dehydrogenase, which is consistent with
the specificity studies on the purified pyruvate and a-ketoglutarate
dehydrogenase complexes from pig heart (38j63)., E. coli (64) and
bovine kidney mitochondria (82).
The assumption of a single dehydrogenase with equal affinities
for each substrate^- predicts that "cold" (non-radioactive) keto
acid (inhibitor) in equal concentration with labeled a-keto acid
(substrate) will result in 50 per cent observed inhibition, based
upon measurement of

14
CC^ evolved.

Production of

14
CO^ will be

inhibited to the extent of seventy-five per cent when the ratio of
"cold" to radioactive keto acid is three to one.

Each of the

branched-chain a-keto acids inhibited the jLn vitro oxidation of
the other two acids (Table 8).

The pattern of these inhibitory

effects approximates the general hypothesis of one catalytic site
for all pairs of the branched-chain a-keto acids.

The rate of

oxidation of pyruvate was substantially reduced by a-ketobutyrate,
a compound which also inhibited decarboxylation of the branched-chain
acids, but to a lesser degree.

a-Ketocaproate and a-ketovalerate,

straight chain analogues of the branched-chain keto acids, KIC and
K IV ,

were able to inhibit significantly the

the carboxyl-labeled keto acids.

14

CO^ production from

A more extensive and quantitative

study of mutual inhibition patterns is presented in a later section.
Parallel responses to various physical perturbing techniques
is sometimes used as supporting evidence for the existence of a
single enzyme, while differential effects of identical treatment
^Michaelis constants were similar, but not identical for KIC,
KMV and KIV (see Table 4).
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TABLE 8

INHIBITION OF a-KETO ACID DEHYDROGENASES BY a-KETO ACIDS3

a r b o x y l - “^ C -la b e le d a - k e t o

a c id ,

(S) = 1 mM

In h ib ito r

KIV

KIC

KMV

KG

Pyr

54
71

2k
^3

33
39

53
74

20
32

36
k2

2k
3^

22
31

°j0 inhibition
C -a -K e to is o v a le ra te

kk

1.0 mM-----3.0 mM----->
C-a-Ketoisocaproate
1.0 mM------3.0 mM-------

12
C-Ct-Keto-(3-methy 1valerate
1.0 mM.... ...
3.0 mM------12„
G-a-Ketobutyrate
1.0 mM------3.0 mM--- ----

12

C-a-Ketocaproate
1.0 mM------3.0 mM-------

12
C-a-Ketovalerate
1.0 mM.......
3.0 mM..... —

76

56

78

52

79

56
77

29

26

66

73
8U

27

*+7
69

67
92

3,

a-Keto acid dehydrogenase activities were measured by quantitation
of the ^ C 02 produced when ■‘-^-carboxyl-labeled a-keto acids were
incubated at 30 C with washed preparations of bovine liver
mitochondria. 1-^C-a-keto a d d s were used as inhibitors. Each
reaction mixture contained, in a final volume of 1.0 ml, in
(jmo1es: mannitol, 150; potassium phosphate buffer, pH 7*2, 33>
N AD , 1.0; L i ^ C o A , 0.6; MgClo, 1.0; CaClg, 1.0; NagCO^., 1.0; 0.05 ml
o f enzym e p r e p a r a t i o n and t n e
s u b s t r a t e and i n h i b i t o r .

in d ic a te d

am ou nts

or a - k e t o

a c id
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upon two activities may indicate separate enzymes.

Figure 28

illustrates the nearly parallel pattern of variation of the branchedchain cc-keto acid dehydrogenase activities during storage of isolated
mitochondria at 1*°C.

All three activities (KIC, KMV, KIV) increased

during the first 2b hours, followed by a gradual decrease in the
succeeding 72 hours.

The slightly different response of KIV

dehydrogenase activity as compared to KMV and KIC activities, could
be a result of experimental variance, or may suggest the possibility
of multiple enzymes.

a-Ketoglutarate dehydrogenase activity,

measured concurrently, did not vary significantly over the entire
96 hour interval.
The data of Figure 29 show that KIC dehydrogenase and pyruvate
dehydrogenase respond differently to preincubation of isolated
mitochondria for varied time intervals at 1+5°C.

KIC dehydrogenase

activity appears to increase, relative to the initial measurement,
subsequent to a short exposure to the b^°C temperature.

Longer

periods of incubation at this temperature resulted in rapid
inactivation of KIC dehydrogenase, while pyruvate dehydrogenase
activity showed a steady decrease for all incubation intervals.

The

response of KMV and KIV dehydrogenase activities closely mimics
that observed for KIC.

Danner (83) had previously noted a similar

response with KIC dehydrogenase of rat liver mitochondria.
When washed preparations of bovine liver mitochondria were
incubated with various concentrations of sodium arsenite the
branched-chain a-keto acid dehydrogenase activities declined at
nearly identical rates (Figure 30)*

Since arsenite is known to form
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Fig. 28. —

Effect of incubation at i+°G on a-keto acid

dehydrogenase activities

Bovine liver mitochondria (25 mg/ml) were stored at 4°C for the
indicated time periods.
in the Methods.

The mitochondria were prepared as described

G-Keto acid dehydrogenase activities were measured

by the ferricyanide reduction assay (see Methods section for
procedure) at each of the stated time periods.
mitochondria was used for each determination.

One-tenth ml of
Activity (in micro

moles per minute) was calculated as described in the Methods.

fi

m ole $ / min. / reaction mixture
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HOURS

Ill

Ft

29,

Inactivation of a-keto acid dehydrogenases with

time of '...cuoai ion at i+5 °C

Washed liver nitochondria were suspended in 0.30 M mannitol at a
concentration n c 23 mg of protein per ml.

The suspension was

incubated in a 45°c bath and 0 .1 ml samples withdrawn and assayed
immediately for dehydrogenase activity with KIC ( 0 - 0 ) and Pyr
(see text or Methods for details).

Zero time assays and

blanks were in triplicate, other points in duplicate.

Activities are

expressed as percentage of activity in samples not incubated at ^5°C.
The

li+
C0o assay method was utilized.

Each reaction mixture contained

the following in a final volume of 1.0 ml (in |umoles) mannitol, 150 ;
potassium phosphate buffer, pH r
J.2, 33> NAD, 1.0; Li^CoA, 0.6; MgC^,
1.0; CaCl2, 1.0; Na^CO^j 1.0; and either l-li+O K I C (3700 cpm per pmole),
2.0; of l-^C-Pyr (58,700 cpm per pmole), 1.0.

s

...

M IN U T E S

AT 4 5 °C
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Fig. 30. -- Inhibition of branched-chain a-keto acid
oxidative decarboxylation by arsenite

Plots of per cent of original activity (in absence of arsenite) vs.
arsenite concentration.

A diluted suspension of fresh mitochondria

(1.25 mg prctein/ml of suspension) was incubated for 10 minutes at
25°C in the presence of the indicated concentration of sodium
arsenite,

JJranched-chain a-keto acid dehydrogenase activity was

measured bj the

lU
CO^ assay as described in the Methods section.

Each reaction mixture contained 0.1 ml of the treated or the untreated
mitochondr ial suspension and 2.0 |j.moles of l-'*' O k e t o acid; (
!§|, KIC,!, (iHi, KIV).
minutes at 30°C.

KMV),

Reactions were allowed to proceed for 10

All other components of the basic reaction mixture

were the same as for Figure 28.

%

OF

INITIAL

ACTIVITY
oo
o

O

o
T
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mercaptides with thiol groups, these data imply the presence of a
sulfhydryl group (or groups) functional in the oxidative
decarboxylation of the branched-chain a-keto acids.

A logical

suggestion, in view of the proposed similarity of the oxidative
pathways of these keto acids to those for pyruvate and a-ketoglutarate, would be that the observed inhibition by arsenite occurs
through oxidation 01 the dithiol of reduced lipoic acid.
Mutual Inhibition In Vitro Among a-Keto Acid Substrates
A thorough investigation of the relative inhibitory interactions
among several a-keto acids, including the branched-chain acids KIV,
KIC and KMV, was initiated.

Two major objectives were first to

determine whether these interrelationships could constitute a
possible physiological regulatory mechanism among the keto acids
under conditions of "normal" a-keto acid levels in mammalian tissues,
and second, to ascertain to what extent the in vitro metabolism of
a-ketoglutarate and pyruvate is affected by the levels of KIV, KIC
and KMV reported to occur in untreated branched-chain ketoaciduria,
a-Keto acid dehydrogenase activity was estimated by measurement
of the amounts of radioactive

II4.
CC^ evolved from carboxyl-labeled

a-keto acids as described under Methods.

Non-radioactive a-keto

acid was utilized as the inhibitor in each of the studies.

Variation

of substrate concentration at each of several inhibitor concentrations
generated the values for the double reciprocal plots shown in
Figures 31 and 32, which illustrate the apparent competitive nature
of the inhibition by KMV and KIV of KIC oxidation.

Reciprocal

plots in Figures 33 and 3^+ illustrate that the oxidative

Fig. 31. —

Lineweaver-Burk plots of the inhibition of a-

ketoisocaproate dehydrogenase activity by a-keto-P methylvalerate

Lineweaver-Burk plots with 1varied substrate. ( 0
2.5 x 10_^M KMV, (
7.5 x 10

-kM KMV.

£

12

C-KMV as inhibitor and 1-

lli

C-KIC as

) no inhibitor, ( J|--------- |§§ )

4k------ J^)

5 x 10~Si KMV, ( O -------- O )

KIC dehydrogenase activity was measured by the

ll).
CO^ assay as described in the following (in famoles):

mannitol,

150; potassium phosphate buffer, pH 7.2, 335 NAD, 1.0; Li^CoA, 0.6;
MgCl^, 1.0; CaCl^, 1.0; Na^CO^., 1.0; the indicated amounts of 1-

lU
C-

KXC (3500 cpm per pinole) and inhibitor, and 0.1 ml of a washed
preparation of bovine liver mitochondria in a final volume of 1.0 ml.
All reactions were allowed to proceed for 10 minutes at 30°C.
nanomoles CO^ per minute per mg of protein).

(v\,
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•-• ^

V V :.C -V

Zj'j&j ^
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Fig. 32. —

Lineweaver-Burk plots of the inhibition of a -

ketoisocaproate dehydrogenase activity by a-ketoisovalerate

Lineweaver-Burk plots with 1varied substrate.

(&

12

C-KIV as inhibitor and 1-

Ik
C-KIC as

--- ) no inhibitor, ( 0 ----------0 )

2.5 x 10

-k
M KIV, ( A ------- A

7.5 x 10

-k
M KIV,

) 5 x 10

-k
M KIV, ( O ------- O )

Each reaction mixture contained 0.1 ml of a washed

preparation of bovine liver mitochondria, and the indicated amounts
of 1-^C-KIC (3600 cpm per |omole) and inhibitor.

All other

experimental conditions, reaction mixture components and assay
methods were as stated for Figure 31 .
per minute per mg of protein).

(v^, nanomoles CO^ produced
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Fig. 33*

Lineweaver-Burk plots of the inhibition of a-

ketoisovalerate dehydrogenase activity by a-ketoisocaproate

Lineweaver-Burk plots with 1varied substrate.

-b

M KIC.

C-KIC as inhibitor and 1-

--- — — ® )

2.5 x 10 Si KIC, ( A — --- A
7.5 x 10

12

1^

C-KIV as

no inhibitor, ( ( -- ------ 1§§ )

) 5.0 x 10 Si Kic, (

Q-----—

O

}

Each reaction mixture contained 0.1 ml of a washed

preparation of bovine liver mitochondria and the indicated amounts
of 1-^C-KIV (3500 cpm per pinole) and inhibitor.

All other

experimental conditions, reaction mixture components and assay
methods were as stated for Figure 31*
produced per minute per mg of protein).

(v^, nanomoles of C0^
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Fig. 3b. —

Lineweaver-Burk plots of the inhibition of a-

ketoisovalerate dehydrogenase activity by a-keto-3 -methylvalerate

Lineweaver-Burk plots with 1as varied substrate.
5 x 10

(

12

C-KMV as inhibitor and 1-

lb

C-KIV

f) ) no inhibitor, (f|-- ----- )

-b
.
-o
M KMV, (jfa--------1.0 x 10 'T-l KMV.

Each reaction

mixture contained 0 .1 ml of a washed preparation of bovine liver
mitochondria and the indicated amounts of 1pmole) and inhibitor.

lb
C-KIV (3500 cpm per

All other experimental conditions, reaction

mixture components and assay methods were as described in Figure 31*
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decarboxylation of K I V is inhibited competitively by either KMV
or KIC in this system.

Production of

lU

CO^ from carboxyl-labeled

KMV is also subject to competitive inhibition by Kid or KIV as
seen in the Lineweaver-Burk plots of Figures 35 and 36.

Thus,

each of the branched-chain a-keto acids is able to compete for
the oxidative process in the mitochondrial system.
The rate of in vitro oxidative decarboxylation of pyruvate
by bovine liver mitochondria was decreased significantly in the
presence of the branched-chain keto acids.

Figure 37 indicates,

in double reciprocal form, that KIC acts as a competitive
inhibitor of pyruvate oxidation.

The Dixon plots (84) of Figure 38

disclose a similar competitive effect for KIV upon the utilization
of pyruvate by bovine liver mitochondria.

The Dixon plots of

Figure 39 illustrate the competitive inhibition of pyruvate
oxidative decarboxylation by KMV.
The catabolism of a-ketoglutarate was inhibited by K I C
(Figure 40), KMV (Figure 4l) , and K I V (Figure 42).

The apparent

•nixed type of inhibition was noted with each of the branched-chain
a-keto acids.

These findings agree with those previously obtained

for the purified a-ketoglutarate dehydrogenase complex from pig
heart mitochondria (38).
The influence of a-ketocaproate (KC), a straight-chain
analogue of KIC and KMV, on the production of
labeled KIC or KIV was also examined.

14
CO ^ from carboxyl-

It was assumed that KC

would act as a competitive inhibitor of the oxidation of these two
branched-chain keto acids, and could thus be used as an agent for
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Fig- 35* —

Lineweaver-Burk plots of the inhibition of a-

keto-f3-met:hylvalerate dehydrogenase activity by a-ketoisocaproate

Lineweaver-Burk plots with 1-

12 C-KIC as inhibitor and carboxyl-

labeled KFV as varied substrate.

(

(S

(

- ----------- -

H ) 2.5

X

Icf^M KIC,

----) no inhibitor,
------- ^

)

7.5

x

10_^M KIC.

Each reaccion mixture contained 0.1 ml of a washed preparation
of bovine liver mitochondria and the indicated amounts of labeled
KMV (2050 cpm per |umole) and inhibitor.

All other experimental

conditions, reaction media and assay methods were as stated for
Figure 3 ..
protein' .

(v., nanomoles C0_ produced per minute per mg of
i
2

1.2

1.0

0.8
0.6

0.4

0.21

127

Fig. 36 . -- Lineweaver-Burk plots of the inhibition of a-keto'
8-methylvalerate dehydrogenase activity by a-ketoisocaproate

Lineweaver-Burk plots with 1-

12

C-KIC as inhibitor and carboxyl-

labeled KIP/ as varied substrate.
( i § ~ -----

-

41

{ Q ----- -- — O

)

)

(

—— —

) no inhibitor,

2.5 x lCfSl KIC, ( £ --- --- ) 5-0 x 10~Sl KIC,
7-5 x 10 Su KIC.

Each reaction mixture contained

0.1 ml of a washed preparation of bovine liver mitochondria,
the indicated amount of labeled KMV (2050 cpm per pinole) and
inhibitor.

All other experimental conditions, reaction media and

assay methods were as stated for Figure 3 !.
produced per minute per mg of protein).

(v^, nanom°les CO^
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1.2

KMVj
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Fig* 37* —

Lineweaver-Burk plots of the inhibition of

>yruvate dehydrogenase activity by a-ketoisocaproate

IP

jineweaver-Burk plots with 1is varied substrate.

2.5 x 10 "\l 1 - 12C-KIC,
O --- —

12

-- O )

C-KIC.

T V.

C-KIC as inhibitor and l-xl+C-pyruvate

( 0 ---- — $

(At—

—

) no inhibitor, ( g§-—

A)

)

7-5 x i o ^ m i - 12c -k i c ,

1.0 X 10"3M 1- 12 C-KIC,

( Q - ------Q )

2.0 x 10""Si

Pyruvate dehydrogenase activity was measured by the

b

C 0 o assay as described in the Methods section.

Each reaction

fixture contained in a final volume of 1.0 ml, the following (in
licromoles), mannitol, 150; potassium phosphate buffer, pH 1.2, 335
iAD, 1.0; Li^CoA, 0.6; MgCl2 , 1.0; CaClg, 1.0; Na 2C 0 3 , 1.0; 0.05 ml
>f a washed preparation of bovine liver mitochondria ( 1 .3 mg protein)
m d the indicated amounts of 1-

lb

C-pyruvate and inhibitor.

•eactions were allowed to proceed for 10 min at 30°C.
:02 produced per minute per mg protein).

The

(v , nanomoles
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PYRUVATE )

x 10 V
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Fig. 38. —

Dixon plot of the inhibition of pyruvate

dehydrogenase activity by a-ketoisovalerate

Dixon plot with 1as substrate,

—
14.

3.0 x 10

12

C-KIV as varied inhibitor and 1-

( # ------ ) 1.0 x 10

14

Ml-

C-pyr.

ll+

C-pyruvate

l - ^ C-pyr ( §§■— —

..... '-fH )

Each reaction mixture contained 0.05 nil of

a washed preparation of bovine liver mitochondria, the indicated
amounts of 1-

14
C-pyr (58,500 cpm Per pmole) and quantities of

inhibitor as noted in the figure.

All other experimental

conditions, reaction media and assay methods were as stated for
Figure 37*
protein).

(v^, nanomoles of CO^ produced per minute per mg of

I

133

Fig* 39* —

Dixon plot of the inhibition of pyruvate

dehydrogenase activity by a-keto-{3-methy lvalerate

Dixon plot with 1as substrate.
1.5

12C-KMV as varied inhibitor and 1- lUC-pyruvate

(||---

-k
lit
x 10 M i- C-pyr.

III) 5 x 10

1 -^C-pyr, ( £ ------- )

Each reaction mixture contained 0.05 nil

of a washed preparation of bovine liver mitochondria with the
indicated amounts of 1-

C-pyr (58,500 cpm per pinole) and inhibitor.

All other experimental conditions, reaction media and assay methods
were as stated for Figure 37*
minute per mg protein).

(v^, nanomoles of CO^ produced per

1o

-3 .0
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F ig .

40. —

k e to g lu t_r a te

L in e w e a v e r -B u r k

dehydrogenase

p lo ts

a c tiv ity

Lineweaver-Burk plots with 1-

12

of

K IC .
*|

( |§~

—

a -K e to g lu ta r a te

in h ib itio n

C-KIC as inhibitor and 1((@—

£

| g ) 5 x lo’^M KIC, ( Jfe-— -- A )
dehydrogenase

o f Qf-

by a - k e t o is o c a p r o a t e

a-ketoglutarate as the varied substrate.
inhibitor,

th e

a c tiv ity

was

14

C-

) no
1-5 x lo”^M

m easured by

th e

|

C0? assay as described in the Methods section (v^, nanomoles CO 2
produced per minute per mg protein).

Each reaction mixture contained

in a final volume of 1.0 ml, the following (in micromoles), mannitol,
150; potassium phosphate buffer, pH "J.2, 335 NAD, 1.0; Li^CoA, 0.6;
MgCl2 , 1,0; CaCl^j 1.0; Na^CO^, 1.0; 0.05 ml of a washed preparation
of bovine liver mitochondria (1 .3 nig protein), and the indicated
am ou n ts

of

in h ib ito r.

30°C.

1-

14

A ll

C -a -k e to g lu ta r a te
re a c tio n s

w ere

,
\
,
(50,000 c p m p e r j j j n o l e ) a n d

a llo w e d

to

proceed

fo r

10 m i n u t e s a t

.^6

_________ i_________
a-KETOGLUTARATE

x io 3 m

1

137

Fig. 4l. -- Lineweaver-Burk plots of the inhibition of aketoglutarate dehydrogenase activity by a-keto-^-methylvalerate

Lineweaver-Burk plots with 1the varied substrate.

12

C-KMV as inhibitor and 1-

( # -------- - # )

5.0 x lo’Sl KMV, ( A -------A )

14

C-KG as

no inhibitor, ( Q — -- ----)

1-5 x 10~\ KMV.

Each reaction

mixture contained 0.05 tnl of a washed preparation of bovine liver
mitochondria with the indicated amounts of 1umole), and inhibitor.

14
,
C-KG (50,000 cpm per

All other experimental conditions, reaction

media and assay methods were as stated for Figure 40.
nanomoles C0o produced per minute per mg of protein).
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a-KETOGLUTARATE j
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Fig. k2, —

Lineaver-Burk plots of the inhibition of a-

etoglutarate dehydrogenase activity by a-ketoisovalerate

ineweaver-Burk plots with 1aried substrate.

( # - ------- 0

.0 x 10"Si KIV, ( A —
.0 x 10 Si KIV.

12

~A)

1U

C-KIV as inhibitor and 1- "C-KG as
) no inhibitor, ( 0 — ----- 0
1.0 x 10"3M KIV, ( O —

)

----- O )

Each reaction contained 0.0p nil of a washed

reparation of bovine liver mitochondria with the indicated amount
f l-^+O K G

(50,000 cpm per jjmole) and inhibitor.

All other

xperimental conditions, reaction media and assay methods were as
tated for Figure b0.
,g of protein).

(v^, nanomoles CO^ produced per minute per

lbl

further investigation of the number of enzymes involved in the
oxidation of KIC and KIV, since if only one enzyme is concerned,
a competitive inhibitor should give the same value of K. when
x

tested with either substrate.

While KC did in fact inhibit the

dehydrogenase activity with either KIC (Figure 1+3) or KIV
(Figure 1+1+), the inhibition appeared to be of a mixed nature.
Though the

values were calculated (2.1+ x 10 Si and 1+.8 x 10 Si),

their value as a diagnostic tool is definitely lessened by the
suggestion that KC may be interacting with the enzyme(s) at
other than the catalytic site since the inhibition observed
appeared to be of a mixed type.

Oxidation of KIV is also inhibited

by its straight-chain analogue, a-ketovalerate (KV), as evidenced
by the data shown in the Dixon plots of Figure 1+5.
observation that the values of

The

for the straight-chain keto

acids KC and KV are somewhat lower (see Table Q) than are the K
values for the branched-chain analogues KIC and KIV may indicate
preference of the enzyme for the unbranched compounds.

This

findings is of only incidental interest at present, since the
physiological function or occurrence of KC and KV have not been
investigated in mammalian tissues.

On the other hand, a-keto-

butyrate (KB), an a-keto acid of considerable importance in the
catabolic pathways of methionine and threonine, has been reported
to accumulate in the plasma of branched-chain ketoaciduric
patients (16).

Recent investigation has shown that KB is

oxidized to propionyl-CoA by the pyruvate dehydrogenase complex
(38) at a substantial rate.

The oxidation of KIC (Figure 1+6)

TABLE 9
K.

i

V A L U E S OF V A R IO U S Qf-KETO A C I D S

ON B O V IN E L I V E R M IT O C H O N D R IA q - K E T O A C I D

DEHYDROGENASE A C T I V I T I E S 8

K. (M)
Inhibitor
a-keto-j3-methylvaierate
dehydrogenase

1 -12C-KMV.....
1-

12

C-KIC... —

i - 12c -k i v .....

1-

u-ketoisoeaproate
dehydrogenase

8 ,6 x 10 il
6.9 x 10“)+
2.2 x 10"if

12

1-1 T-KB......

2.5 x I0~h
1.3 x 10

1.95 x 10

-h

12C-KV..... -

i - 12c -r c ------

a-ketoisovalerate
dehydrogenase

0.5 x 10
2.2 x 10 4
1 .1 x lo” 3

pyruvate
dehydrogenase

a-ketoglutarate
dehydrogenase

l.k x 10~3

2 .3 x l o ” 3
1
-k
5 .1* X 10

2,k

uk

8 .2 x 10 +

X

10~3

x

-1+

U .8 x 10'1*
k.l x 10 ^

a
ll|
a-Keto acid dehydrogenase activities were measured by quantitation of
CO^ produced from
carboxyl-labeled a-keto acids.
Reaction conditions and assay methods are described in the legends to Figures 31-l+Y and in the
Methods. Each K. value tabulated represents the average of at least three determinations.
i

lo ’ 3

Ik 3

fig* 43. ”

Lineweaver-Burk plots of the inhibition of

a-ketoisocaproate dehydrogenase activity by a-ketocaproate (KC)

Lmeweaver-Burk plots with 1-

12
lk
C-a-KC as inhibitor and 1- C-

KIC as the varied substrate.
H I — -- -— H I ) 5*0 x 10

M 1-

^ ) no inhibitor,
C-KC.

a-Ketoisocaproate

dehydrogenase activity was measured by the IkCO^ assay as described
in the Methods section.

Each reaction mixture contained in a

final volume of 1.0 ml, the following (in micromoles), mannitol, 150 ;
NAD, 1.0; Li^CoA, 0.6; MgCl2, 1.0; CaCl2, 1.0; Ha^CO^, 1.0; 0.1 ml
of a washed preparation of bovine liver mitochondria (2.6 mg protein),
and the indicated amounts of 1-

lk

C-KIC and inhibitor.

were allowed to proceed for 20 minutes at 30°C.
produced per minute per mg protein).

All reactions

(v^, nanomoles C0 2

' !'

; : v ':■:'
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Fig, 44, -- Lineweaver-Burk plots of the inhibition of aitoisovalerate dehydrogenase activity by a-ketocaproace

.neweaver-Burk plots wich 1td 18-

12

C-Q!-ketocaproate (a-KC) as inhibitor

14
C-a-KIV as varied substrate,
.~~— SI) 1.0 x 10

-4

M a-KC.

tivity was measured by the
ithods section (v^
otein).

,^

) no inhibitor,

a-Ketoisovalerate dehydrogenase

14
CO^ assay as described in the

nanomoles CO^ produced per minute per mg of

Each reaction mixture contained in a final volume of

0 ml, the following (in micromoles), mannitol.

150;

potassium

osphate buffer, pH 7,2, 33* P-NAD, 1.0; Li CoA, 0.6; MgCl0, 1.0;
Cl^j 1.0; Na^CO^, 1.0; 0.1 ml of a washed preparation of bovine
ver mitochondria (2.6 mg protein), and the indicated amounts ox
14

C-KIV and inhibitor.

minutes at 30°C.

All reactions were allowed to proceed for
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Fig. 1+5. —

Dixon plot of the inhibition of a-ketoisovalerate

dehydrogenase activity by c.-ketovalerate (KV)

Dixon plot with 1-

C-KV as the varied inhibitor and 1-

as the keto acid substrate.
( H --- --- ■ )

(#— — — — #)

2.5 c 10~Sl KIV-l-^C,

5.0 x l O ^ M KIV-l-^C, l-li+C-KIV.

dehydrogenase activity was measured by the
in the Methods section.

C-a-KIV

a-Ke to iso vale rate

114CO^ assay as described

Each reaction mixture contained in a final

volume of 1.0 ml. the following (in micromoles); mannitol, 150;
potassium phosphate buffer

pH 7«2, 335 NAD, 1.0; Li CoA, 0.6; MgCl„,

3

1.0; CaCl^, 1.0; Na^CO,, 1,0; 0.1 ml of a washed preparation of
bovine liver mitochondria, and the indicated amounts of 1-^C-KIV
and inhibitor.
at 30°C.

The react:.ons were allowed to proceed for 10 minutes

(v^, nanomoles CjQ^ per minute per mg protein).

sj,. ?
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Fig. 46. -- Lineweaver-Burk plots of .he inhibition of CCketoisocaproate dehydrogenase activity by a-ketobutyrate (KB)

Lineweaver-Burk plots with 1as varied substrate.

12
14
C-KB as inhibitor and 1- C-KIC

( B ------- no inhibitor, ( ■ ------------ B )

0.25 mM KB, ( ▲ -- -----

A)

0.75 mM KB, ( O ------- - o ) 1.50 ml! KB.

Each reaction mixture contained 0.1 ml of a washed preparation
of bovine liver mitochondria (2.4 mg of protein) with the indicated
amounts of 1-^C-KIC (36OO cpm per pinole) and inhibitor.

All

other experimental conditions, reaction media, and assay methods
were as stated for Figure 43.
minute per mg protein).

(v^, nanomoles C0^ produced per
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and

of

pyruvate (Figure ^ 7 ) was affected deleteriously by low

levels of KB in vitro.
The results from the inhibition studies illustrated by Figures
31 to k j and summarized in Table

9

indicate that the metabolism of

these keto acids is markedly influenced by the relative levels of
the various a-kefo acids in the normal liver cell (see Appendix II
for normal levels of some amino acids and keto acids).

From these

data it is evident that one consequence of increased KIC
concentrations will be the effective and detrimental influence
upon the conversion of pyruvate to acetvl-CoA by pyruvate
dehydrogenase.

Further implications of the mutual interactions

among the a*keto acids KMV. KIC and KIV and the effects of these
keto acids on the catabolism of a-ketoglutarate and pyruvate with
reference to the normal metabolism of the liver and with respect
to the aberrant situation associated with the diseased (branchedchain ketoaciduria) state will be considered in the "Discussion".

Fig. I4.7 . —

Lineweaver-Burk plots of the inhibition of

pyruvate dehydrogenase activity by cc-ketobutyrate

bineweaver-Burk plots with 1-

12
lit
C-KB as inhibitor and 1~ 'C-pyruvate

(52,600 cpm per pmole) as the varied substrate.
inhibitor, (H “ ------H

0.25 mM KB,

( ^ — — — — — -^) no
) 0.75 mM KB.

Each reaction mixture contained 0.05 ml of a washed preparation
of bovine liver mitochondria (1.2 mg of protein) with the indicated
amounts of l-^C-pyr (58,500 cpm per jjinole) and inhibitor.
Reactions were allowed to proceed for i0 minutes at 30°C.

All other

experimental conditions, reaction media and assay methods were as
stated for Figure 1+3.
of protein).

(v., nanomoles C0o produced per minute per mg
x
2
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DISCUSSION
A comprehensive delineation of the intricate regulatory
mechanisms which modify the catabolism of the branched-chain amino
acids is only recently emerging from several investigations of
the catabolic enzymes.

The major thrust of initial studies of

the metabolism of the oranched-chain amino acids centered upon
the characterization of the overall degradative pathways of leucine,
isoleucine and valine (l); elucidation of the site of the catabolism
of these compounds in the genetic disease branched-chain ketoaciduria (21,23,24) and development of therapeutic dietary
treatment designed to control the symptoms of the disease (20,32).
Recently however, there has been evidenced a growing awareness of
the complexity and multiplicity of the regulatory mechanisms which
may function to maintain a fine balance among the cellular levels
of the branched-chain amino acids and keto acids in the normal
mammalian system.
A thorough description of the regulation of the metabolism of
these compounds must integrate such known facts as the variation
in distribution among tissues of the transaminases and ct-keto acid
dehydrogenases, differences in the adaptive responses of these
enzymes to variation in diet or availability of substrates, and the
number and specificities of these enzymes.

Furthermore, of

considerable importance to such a discussion is the consideration
of tne mode and extent of any mutual interferences among these
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reactions.

The influence of permeability barriers between substrates

and enzymes imposed by physical compartmcntation of constituent
enzymes involved with the catabolic sequence may also contribute
to the overall control apparatus.
The metabolism of the amino groups of leucine, isoleucine and
valine appears to be regulated by several factors, including the
availability of amino group acceptor (l6) and induction
transferase enzymes (11,85).

of amino

That the further catabolism of these

amino acids is subject to genetic control is evident from the
studies of Wohlheuter and Harper (ll), who have shown a parallel
increase in the branched-chain a-keto acid dehydrogenase activities
in response to increased dietary intake of protein.

During the

course of their investigations of this phenomenon, they noted a
second modulation of the dehydrogenase activities, not affected
by known inducing agents, which was tentatively identified as a
pattern of diurnal variation.
A substantial elevation of the plasma levels of the branchedchain amino acids occurs in animals fed a diet high in prctein.
For example, Anderson ejt al. (86) have reported leucine concentrations
of approximately 10

-li

M in the plasma of rats fed a controlled diet

containing five per cent casein hydrolysate.

However, within one

day after initiation of a force-fed diet which contained 25 per
cent protein, the levels of leucine increased nearly five-fold.
Leucine, isoleucine and valine concentrations remained elevated
for two to three days if the 25 per cent casein diet was continued,
then decreased gradually to a steady state slightly higher than was
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It has been variously postulated that one, two or even three
separate enzymes may be responsible for the oxidative decarboxylation
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of KIC, KMV and KIV in mammals.

The combined substrate experiments

performed in these studies imply the existence of a single
dehydrogenase, as do the similar responses, jLn vitro, to perturbing
influences such as subjection to mild heating, pH variation, and
arsenite treatment.

Mutual inhibition among KIC, KMV and KIV

(Table 8) approximate that which will be expected for competitive
interaction at a single binding site.

However, the values for K
’
m

and K. which were determined for the branched-chain keto acids are
i
sufficiently similar so that the observed pattern could be
attributed to the influence of multiple dehydrogenases for KMV, KIC
and KIV.

Nevertheless, the weight of evidence from this work appears

to favor the former hypothesis.

Ultimately the acceptance of a one

enzyme model requires the demonstration of a single homogeneous
enzyme complex having activity with all three keto acids.
The assumption of a single branched-chain a-keto acid
dehydrogenase from mitochondria should not he construed as contra
dictory to the demonstration, by Connelly et al. (27,80), of a
soluble KIC-KMV dehydrogenase from bovine liver cell preparations.
This enzyme was partially purified, and by a variety of criteria,
was considered to be a single enzyme.

The subcellulir distribution

studies reported here indicate that in bovine liver, the
dehydrogenase activity with KIC, KMV and K I V is predominantly
associated with the mitochondria, with roughly ten per cent of the
total decarboxylase activity with either KMV or KIC occurring in
the "soluble" (jL.e,. not sedimented at 80,000 x
fraction.

for one hour)

Very little KIV decarboxylase activity was detected in
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the soluble phase.

In contrast to the notable dependence of the

mitochondrial enzyme activities upon exogenous NAD+ and CoA, the
soluble activities exhibited some requirement for NAD+, but no
observable, need for added CoA.

These results merit discussion in

view of the observed absence of branched-chain keto acid dehydro
genase activity in branched-chain a-keto aciduria (BCKA).

If two

types of branched-chain keto acid dehydrogenase exist, one
localized in the mitochondria and another in the soluble phase of
the cell

they are evidently closely’’ related at the genetic level.

Loss of these enzymatic capabilities, through an inherited genetic
lesion, would then result in total inability (in classic branchedchain ketoaciduria) to catabolize these keto acids.
It is generally accepted that the oxidative decarboxylation of
pyruvate and a-ketoglutarate, in mammalian tissues, is catalyzed by
separate dehydrogenases complexes (38), each possessing a relatively
high degree of substrate specificity.

O-Ketoglutarate dehydrogenase

in nearly completely specific for a-keteglutarate with a minor ability
to decarboxylate a-ketoadipate.

On the other hand, the pyruvate

dehydrogenase of pig heart mitochondria is capable of oxidizing
either pyruvate or a-ketobutyrate at substantial rates (38).

Studies

reported here, i.e. differential response of these activities to
mild heating, and nearly additive reaction rates in the mixed
substrate experiments (Table 7 ) support the conclusion of separate
a-ketoglutarate and pyruvate dehydrogenase complexes in bovine liver
mitochondria.
Close scrutiny of the data shown in Appendix II will reveal that
protein intake (discussed above) results in accumulation of KIC, KMV
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and KIV in concentrations which approach, and in some instances exceed
the calculated inhibition constants for these keto acids (see Table 9)
For example the concentration of KIC may reach 0.5 mM, which is
significantly greater than its inhibition constant against KIV
dehydrogenase activity.

These mutual inhibitory interactions among

the branched-cfciain a~keto acids would thus enable the organism to
maintain cellular homeostasis by permitting the preferential oxidation
of a particular keto acid present in excess amounts.

This phenomenon

could attain a significant physiological role in the event of a
disparity in the concentration of these metabolites in the tissues.
In dietary intake of protein from certain sources, for example,
large amounts of milk protein, which has a high leucine content (32),
the situation described above would be expected to occur quite
commonly.
Possibly the most important consequence of elevated branchedchaln amino acid and a-keto acid concentrations in the cells is the
potential modulating effect of these acids upon the utilization of
carbohydrate.

As can be seen in Table 9 , each of the branched-chain

Oi-keto acids is able to inhibit the oxidatior of pyruvate and 0Lketoglutarate.

The apparent inhibition constant (K^) for KIC

against the effective pyruvate dehydrogenase activity was determined
to be approximately 0.5 mM.

When the level of KIC in plasma and

liver increases subsequent to high dietary consumption of protein,
this K. is sufficiently low so as to allow a marked reduction in the
r
rate of oxidation of pyruvate to acetyl CoA.
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Kinetic constants, K , were determined conventionally by
application of the relationship shown in equation 12.

Furthermore,

since the inhibition of pyruvate oxidation by KIC is of the
competitive type, equation 13 was applicable for the calculation
of the inhibitor constants, K.. Use of these constants then
allowed for calculation of the per cent inhibition of the
dehydrogenase activity with equation lh, as proposed by Nordlie
(87), at any suitable levels of substrate and inhibitor (v. as
used in equations 13 and 14 refers to the initial reaction
velocity in the presence of inhibitor).
V
/pyruvate/
max — ^
—
+

(12 )

/pyruvate^/

V
/pyruvate/
max
—
(13/

iKIC/
1 + ---------- | k
K.

| m

Per cent inhibition =

/pyruvate/

(v - v .) x 100
______ 1_______

Pyruvate concentrations in rat liver are reported to range from
0.034 mM for 2k hour fasted animals to approximately 0.2 mM in
the fed rat (88).

Assuming that these results can be extrapolated

to other mammals, the following situations would obtain.

In

mammalian liver, KIC concentrations of about 0.1 mM (lower end of
the normal range, see Appendix II) would decrease the pyruvate
dehydrogenase activity only slightly (five to ten per cent) in the
fed animal.

However, if the level of KIC reaches a somewhat

elevated concentration, such as is known to occur after consumption
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of increased amounts of protein, inhibition is considerably greater
(about 35 per cent).

Under these conditions, this represents nearly

a four-fold potentiation in the inhibition of pyruvate oxidation.
By comparison, KMV concentrations in the normal range of 0.08 mM to
0.2 mM (see Appendix II) would result in merely a two to five per
cent inhibition of pyruvate dehydrogenase activity in the fed animal.
In contrast, the oxidation of a-ketoglutarate is less likely to
be influenced by these conditions, since the reported levels of plasma
and liver branched-chain a-keto acids remain somewhat below the
apparent K_ values for KIC, KMV and KIV against the a-ketoglutarate
dehydrogenase activity.

By way of illustration, continued

administration of a 25 per cent casein hydrolysate to diet-stabilized
rats caused the concentration of a-ketoisocaproate to rise
significantly, to a value of approximately 0.^ mM.
is considerably lower than the estimated

This concentration

(2.^ mM) for KIC.

A second, indirect effect of elevated KIC, KMV and KIV lies in
the fact that the catabolism of these compounds leads ultimately to
succinyl-CoA and acetyl-CoA., each of which has been reported to
inhibit the enzymatic functions of a-ketoglutarate dehydrogenase and
pyruvate dehydrogenase ( 8 9 ) .

The combined effects of these direct

and indirect inhibitions by branched-chain a-keto acids on the
metabolism of pyruvate and a-ketoglutarate could thus constitute a
significant physiological regulatory phenomenon.

In this way, the

branched-chain a-keto acids may be able to promote their own
catabolism, since oxidation of excess branched-chain compounds would
be favored, until normal cellular concentrations are reattained,
at which time the inhibitory effects would become slight.
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Other potential points of inter-regulation of branched-chain
a-keto acid catabolism are suggested by the effects of added Mg+ ^
and ATP.

Linn, Pettit and Reed (90) have recently reported that

mammalian pyruvate dehydrogenase is inactivated by ATP in the
presence of a specific kinase enzyme.

A phosphatase, in the presence

of Mg'^, reactivates the pyruvate dehydrogenase complex.

While

speculation that a similar sequence of events may function to
regulate the catabolism of the branched-chain a-keto acids is
intriguing, the ultimate proof of such a mechanism will depend
upon eventual isolation of the dehydrogenase complex.

The dramatic

stimulation of branched-chain a-keto acid dehydrogenase activity
of whole mitochondria by Ca
understood.

+2

and inorganic phosphate is not

A similar effect of Ca

+2 on this activity was noted

by Wohlheuter and Harper (ll) in rat liver mitochondria.

They also

utilized rather high concentrations of phosphate buffer (150 mM),
but apparently did not investigate the effects of this agent on
the branched-chain a-keto acid dehydrogenase activities.
phosphate (9 1 ) and Ca^

Inorganic

(92 ) are known to be potent mitochondrial

swelling agents at the concentrations utilized in the assay medium
upon which these studies are largely based.

The possibility that

changes in the structural state of mitochondria give rise to the
observed enzymatic changes can not be disregarded.
intramitochondrial concentrations of Mg

The relative

+2 , Ca +2 , ATP and P^ may

provide a finely intermeshed regulatory system to supplement
the major regulatory aspects mentioned earlier in this discussion.

5-63
Interposition of a physical barrier such as a biological membrane
between a metabolite and an enzyme functioning in the conversion of
that metabolite may introduce an additional regulatory aspect.
The selective permeability of the inner membrane of mammalian
mitochondria could constitute such a barrier.

If the metabolite

is formed outside of this membrane, and is to be catabolized inside
of the membrane, that substrate must either diffuse through or be
transported across the membrane barrier.

The enzyme localization

studies presented here, which indicate that the branched-chain aketo acid dehydrogenase oxidation site is on the outer face of the
inner membrane, would apparently abolish the consideration of
permeation of substrate or translocase action as a factor
controlling the oxidation of the branched-chain ct-keto acids.

In

contrast, the mixed type of inhibition of a-ketoglutarate
dehydrogenase activity, which was noted above, could in theory
reflect dual inhibitory effects of the branched-chain a-keto acids
at the a-ketoglutarate translocase (53) site, and at a catalytic
site on the enzyme within the mitochondrial inner membrane.
Although the localization studies predict that pyruvate dehydrogenase
faces the matrix side of the inner membrane, earlier stuoies have
demonstrated that pyruvate can transverse the inner membrane with
little difficulty (93)•
Among the outstanding biochemical characteristics of the
disease branched-chain ketoaciduria are (a) abnormal accumulation
of leucine, isoleucine and valine in the brain, liver, plasma and
spinal fluid; (b) a corresponding increase in the branched-chain
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a-keto acid ( K I C , KMV, K I V ) concentrations in these same tissues;
and (c) extraordinarily large amounts of these amino and a-keto acids
in the urine of the diseased patients (17).

The distinctive maple

syrup odor of the urine and other bodily secretions has been
attributed to the accumulation of a polymeric form of a-hydroxybutyrate derived from a-ketobutyrate (9^+.>95)> or to the presence
of a-keto-p-methylvaleric acid (KMV) (19 ).

Menkes (17 ) reported

that the excretion of pyruvate and a-ketoglutarate in the urine
of persons with branched-chain ketoaciduria was normal.

In a more

recent communication, however, Woody (96) indicates that a-ketoglutarate levels of the urine increase significantly in those
patients showing advanced neurological symptoms of the disease.
Increased excretion of this compound could be a consequence of theffective inhibition of a-ketoglutarate oxidation by the branchedchain a-keto acids or alternatively by an inhibitory effect of
these keto acids on reabsorption of KG in the renal tubules, as
was suggested by Lysiak et_ al. (97)«
Inhibition of the activity of pyruvate dehydrogenase by KIC has
been investigated semi-quantitatively in rat liver (37^39) and
brain (37)*

Kanzaki e_t al. (38) have shown that KMV and KIV

inhibit the activity of the purified pyruvate dehydrogenase from pig
heart.

They did not establish the inhibitory capacity of KIC upon

pyruvate dehydrogenase activity because they considered this keto
acid as a substrate.

Their results, which describe an apparent

Michaelis constant value of 1+.3 x 10

_2

M for KIC, indicate that this

branched-chain a-keto acid is an extremely poor substrate for the
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pyruvate dehydrogenase complex,

formal levels of KIC in the liver

cell are two to three orders of magnitude below the K that they
m
have specified.

In general, the results obtained here dealing

with the effects of the branched-chain a-keto acids on bovine
liver pyruvate dehydrogenase correspond closely to those determined
for the purified complex.

As was noted earlier, the branched-chain

a-keto acids are also capable of inhibiting the oxidative decarboxyl
ation of a-ketoglutarate.

Based upon the apparent inhibition

constants (Table 9 ), each of which was found to be near 10

and

the reported concentrations reported for the branched-chain a-keto
acids in the branched-chain ketoaciduria individuals (see Appendix
II), a significant depression of a-ketoglutarate dehydrogenase
activity would be likely to result.

That the inhibitory effects

on a-ketoglutarate dehydrogenase are evident only when tissue
levels of KIC, KMV and KIV are highest is consistent with the
previous observation that a-ketoglutarate accumulates in the plasma
and is excreted in abnormal amounts by the kidney during the semicomatase, ataxic state of the terminal stages of the disease.
Although the exact cause of the neurological pathology commonly
associated with branched-chain ketoaciduria is not known, a
correlation between the neurologic symptoms and elevated leucine
and KIC has been established (19).

The results of the mutual

inhibition studies which were summarized in Table 9 disclose that
KIC is the most potent inhibitor of pyruvate oxidation among tne
three branched-chain keto acids.

Concentrations of KIC have been

reported to exceed 2.5 tilt in plasma, and 0.8 mM in brain tissue of
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BCKA patients (18,19*37)•

It Is evident that the metabolism of

pyruvate dehydrogenase would be severely impaired by these
concentrations of KIC, which range from two to five times the
calculated value for the K. (0.5^ mM) of this branched-chain keto
acid.

The effects of KMV and KIV on the oxidative decarboxylation

of pyruvate would be minimal by comparison to those of KIC, in view
of their considerably higher inhibition constants on pyruvate
dehydrogenase.
The observed accumulation of a-ketobutyrate in tissues of
persons afflicted with branched-chain ketoaciduria may also result
from inhibition of the pyruvate dehydrogenase complex, if in fact
this enzyme is the primary decarboxylase of a-ketobutyrate.
The decreased production of acetyl CoA from pyruvate, which
is a natural result of the obstruction of pyruvate dehydrogenase
activity, has at least two major consequences.

The first, and

probably the more important of these effects, is the limitation
placed upon the amount of acetyl-CoA entering the tricarboxylic
acid cyle from carbohydrate metabolism.

This phenomenon, coupled

with the simultaneous inhibition of a-ketoglutarate dehydrogenase
activity, would greatly diminish the total energy production by
the affected tissues.

Secondly, reduced availability of acetyl-CoA

would have a depressing effect upon lipid synthesis, necessary for
the deposition of myelin in the developing brain.

Decreased

myelination in certain primitive areas of the brain has been proposed
as a contributory factor to the mental deficiencies of untreated
branched-chain ketoaciduria (9^-) •

Elevated levels of KIC are also
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theorized to affect the synthesis of the cerebronic acids which
are essential for myelin formation (3^)*

It should be noted that

clinical studies indicate that the lack of myelination which does
occur is probably not in itself sufficient to account for the
acute neurological syndrome (19 .,3^-)*
Finally, two other effects of elevated branched-chain a-keto
and amino acids have been noted.
acids in the range of 10

Concentrations of these amino

- -3
M are known to inhibit the activity of

ornithine-keto acid transaminase (OKT), an enzyme which has a role
in regulating the activity of the Krebs urea cycle (98).

Impaired

function of this pathway would be expected to have an undesirable
influence upon the nitrogen metabolism of the organism.

Excessive

leucine (2 rriM) and alloisoleucine are known to induce hypoglycemia
and to inhibit glueoneogen.esis from lactate (llO,^l,42) .

The site

of this inhibition has not been elucidated.
In general, then, a variety of potentially deleterious
consequences of the reduced ability of the organism to metabolize
a-ketoglutarate and pyruvate may be expected to underlie the
symptoms and pathology of branched-chain ketoaciduria.

The

catabolism of carbohydrate by the Krebs tricarboxylic acid cycle,
to which pyruvate dehydrogenase is an important point of entry
and of which a-ketoglutarate dehydrogenase is a part, is responsible
for production of a significant portion of the reduced pyridine
nucleotide (NADH) necessary for the subsequent formation of high
energy phosphate bonds.

Interference with these processes through

the effective inhibition of pyruvate and a-ketoglutarate oxidation
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would seriously affect the ability of the organism to maintain
the desired cellular homeostasis, and would decrease the anabolic
capacity of the affected tissues.
Thus, in the normal, and certainly more so in the abnormal
(excess branched-chain amino and a-keto acids) mammal, fluctuations
in the levels of branched-chain a-keto acids could contribute
significantly to the regulation of the levels of these metabolites,
to the status of the rates of pyruvate and a-ketoglutarate
metabolism, and to the resulting metabolic consequences.

APPENDICES

APPENDIX I

Appendix I describes the preparation of some reagent
solutions.
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A.

Prepar- cion of 2 % (w/v) Digitonin Solution.
Add fivi ml of warm 0.25 M sucrose to 0.1 g of powdered
digitoni .

Mix briefly.

in an ult -asonic bath.

Sonicate for one to two minutes
The resulting clear solution

remains cl 2ar foi. 3*D to 60 min at 30°C.
3.

Triton-Uree Reagent (if%).
Saturate 50 1 ml of distilled-deionized water with solid
urea at room temperature.

Add if °
j0 (by volume) Triton X-100

detergent.
C.

Biuret Reagent.
Dissolve 6.0 1 of sodium-potassium tar”rate in 500 ml of water.
Add 1.5 g of ::uS0^*5H20.
hydroxide sol '.tion.

D.

Combine with 300 ml of 10 % sodium

Dilute to one liter with water.

Folin-Ciocalt.au Reagents (for Lowry protein determinations).
Reagent A:

ombined 20 g of Na^CO^, if g of solid NaOH. and
!00 mg cf sodium potassium tartrate.

Dilute to

one liter with distilled-deionized water.
Reagent B:

Combine five grams of CuSO^^H^O with one liter
of water.

Reagent Cr

Combine 50 parts Reagent A with one part
Reagent B.

Prepare fresh daily.

APPENDIX II

Concentration ranges for some amino acids and a-keto acids
in normal mammalian tissues and in human tissues from individuals
with branched-chain ketoaciduria.
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TABLE 10
SOME AMINO ACID AND a-KETO ACID CONCENTRATIONS IN NORMAL AND BRANCHEDCHAIN KETOACIDURIC TISS JE FLUIDS

Amino
Ac id

Normal
i
Concentration
Range
mM

BCKAa
Concentration
Range

a-Keto
Acid

Approximate
Normal
Range
mM

mM

Leucine

o . i - 0.5

-

a-ketoisocaproate

o . i - 0.5

Leucine

0 .1 - 0 .4

4 -6

a-ketoisocaproate

o . i - 0 .4

Leucine

0 .0 1

Isoleucine

0 .0 8 - 0 .2

Iscleucine

0 .0 7 - 0 .2 5

Isoleucine

o .o o 4

Valine

o . i - 0 .4

0 .4 3

0 .0 1

a-Ketoisocaproate
a-keto-(3methylvalerate

0 .0 8 - 0 .2

l.o - l.5

a-keto-pmethylvalerate

0 . 0 7 - 0 .2 5

0 .2 2

a-keto-pmethvlvalerate

o .o o 4

-

-

a-ketoisovalerate

0 .1

- 0 .4

Approximate
BCKA
Range

Tissue

References

mM
rat liver

2 -4

(8 6 )(9 9 )

human plasma

(1 9 )

0 .4 3

human spinal
fluid

(19)

-

rat liver

(9 9 )

1 .0 - 1 .5

human plasma

(1 9 )

0 .2 2

human spinal
fluid

(1 9 )

-

rat liver

(9 9 )

Oo

i

TABLE 10 —

Am i no
Ac id

Normal
Concentration
Range

BCKAa
Concentration
Range

Ct-Keto
Acid

Continued

Approximate
Normal
Range

Approximate
BCKA
Range

Tissues

References

Valine

0.2U

1 .8 5

dt-ketoisovalerate

0 .2 5

1 .8 5

human plasma

(19)

Valine

0 . 011 +

0 .3 2

a-ketoisovalerate

0.011+

0 .3 2

human spinal
fluid

(19)

pyruvate

0 .2

-

rat liver
(fed)

(88)

pyruvate

0 .0 3

-

rat liver
(88)
(2l+ hr. fast)

BCKA is the abbreviation for branched-chain ketoaciduria.
^Based on a K

of approximately one for the transamination reaction (ll+).
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